{"articles": [{"article_id": "M.1456038556.A.B0C", "article_title": "Re: [新聞] 浩鼎乳癌新藥解盲　有利免疫抗體生成", "author": "BAINE (請愛平頭男)", "board": "Stock", "content": "其實剛剛看大家一遍悲觀 還有人說因為很燒錢 所以台灣不該發展新藥 也不該發展生技 這種邏輯超怪的 只要研發有成有希望 燒掉的錢其實 並不是政府 外資也會投入 所以那些認為發展生技 台灣會因為燒錢而亡國的邏輯 真的是很無言 但在股版應該一堆人認為有理吧 其實看看台灣目前還有什麼 產業可以挹注 難道永久當代工 賺毛三到四 燒肝救台灣 生技本來就風險高 一般新創玩不起 政府當然咬有所挹注 讓這些公司 有機會受國外投資者青睞挹注資金 散戶的錢不在眼裡 政府要長遠規劃 風險雖大但不得不做 但也燒了不少肝 這種概念就是一隻牛爸跟牛兒說 兒子啊不要抱怨只能被圈養 要不是這樣你能吃的飽嗎？ 隔天牛爸就被抓去宰了 不要這麼膚淺 新藥成功會帶動相關產業 因為很多觀望者 會同時跟進 那就可以創造就業 你是有多恨你老闆XD 其實這種心態就如台灣演藝圈一樣 就算節目花錢去做 難道可以拼過韓國 所以只需花小成本做談話性節目即可 這樣確實可維持生息 但早晚被打趴 難道政府該持續做苟延殘喘的政策嗎？ 想想一支手機我們能賺的是多少 品牌大廠是多少 當政府挹注發展在代工上 整體收益又能夠有多少 台灣人拼死活幫國外大廠工作 未來可能幫中國工作 就是因為不思把主導權掌握在自己身上 爆不爆肝 當然狹隘一點的想法是 因人而異 但是放在國家發展上 卻是一點一滴的 被侵蝕 現在你沒感覺 花個十年後 再去感嘆 早知道要發展.... 那都來不及了 成熟一點好不好？ 你在意的是你的荷包 國家在意的是長遠發展 散戶把自己看的太高了 那點錢 誰要坑殺你啊 暈 這都大資產在玩的 成熟一點好不好 原來這樣就算大絕XD 可以理性點嗎？ 本來就是 沒那個屁股就別吃那種瀉藥 投資本來有賺有賠 只是因為小小的自己賠錢 就說發展新藥的台灣要亡國了 真是心中小宇宙無限放大XD 那什麼都不要做最好？ 其實政府就是抓大趨勢方向帶頭衝 下面當然會有狗屁倒灶的事情 但不應該因為瑕疵而放棄大戰略 那永遠只能原地踏步 而台灣目前就是如此 不進則退", "date": "Sun Feb 21 15:09:14 2016", "ip": "61.231.187.240", "message_count": {"all": 78, "boo": 6, "count": 9, "neutral": 57, "push": 15}, "messages": [{"push_content": "…", "push_ipdatetime": "02/21 15:11", "push_tag": "→", "push_userid": "soaringwings"}, {"push_content": "我也這樣認為 股價都超級偏低的! 浩鼎沒破千 可能嗎", "push_ipdatetime": "02/21 15:11", "push_tag": "推", "push_userid": "fish19831012"}, {"push_content": "跟玩股票的人講道理 大家看的是紅心Ｋ說話", "push_ipdatetime": "02/21 15:11", "push_tag": "推", "push_userid": "dahlia7357"}, {"push_content": "這些公司 將來都有機會成為全世界的指標", "push_ipdatetime": "02/21 15:12", "push_tag": "→", "push_userid": "fish19831012"}, {"push_content": "魚大 ……XD", "push_ipdatetime": "02/21 15:12", "push_tag": "推", "push_userid": "goodkilua"}, {"push_content": "問題就是丟這麼多錢到底賺不賺的回來？", "push_ipdatetime": "02/21 15:12", "push_tag": "推", "push_userid": "a6565a1"}, {"push_content": "哪有這麼容易亡國的啦", "push_ipdatetime": "02/21 15:13", "push_tag": "推", "push_userid": "icome"}, {"push_content": "新藥這麼容易研發成功的話 諾貝爾獎都要留在台灣了", "push_ipdatetime": "02/21 15:13", "push_tag": "推", "push_userid": "crazysinger"}, {"push_content": "通通都被低估了...淨值比 沒給的300倍 真的扯", "push_ipdatetime": "02/21 15:13", "push_tag": "→", "push_userid": "fish19831012"}, {"push_content": "魚大 帥喔", "push_ipdatetime": "02/21 15:13", "push_tag": "推", "push_userid": "gg889g8"}, {"push_content": "台灣 南波萬~!! 星期一 應該有機會反映價值面", "push_ipdatetime": "02/21 15:14", "push_tag": "→", "push_userid": "fish19831012"}, {"push_content": "前提是研發有成有希望", "push_ipdatetime": "02/21 15:14", "push_tag": "推", "push_userid": "knownany"}, {"push_content": "藥從研發到臨床上市要花十年 電子產品不用這麼久", "push_ipdatetime": "02/21 15:15", "push_tag": "→", "push_userid": "jackliao1990"}, {"push_content": "專利都在國際大廠手上 研發出來也被告到爽", "push_ipdatetime": "02/21 15:16", "push_tag": "→", "push_userid": "jackliao1990"}, {"push_content": "你真的知道新藥公司在玩啥嗎 在玩創投賣公司的", "push_ipdatetime": "02/21 15:17", "push_tag": "噓", "push_userid": "wayne0218"}, {"push_content": "把戲 根本不是提升經濟 創造就業的長久之計", "push_ipdatetime": "02/21 15:18", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "生技拿來炒股不錯  創造就業就算了", "push_ipdatetime": "02/21 15:18", "push_tag": "→", "push_userid": "jackliao1990"}, {"push_content": "整天只會講毛三道四 怎不講養活多少家庭", "push_ipdatetime": "02/21 15:19", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "就連三星也只敢玩生技代工就知道了", "push_ipdatetime": "02/21 15:19", "push_tag": "→", "push_userid": "jackliao1990"}, {"push_content": "還要政府挹注新藥  成功了也只是賣股票的賺錢 笑了   02/21 15:20", "push_ipdatetime": "", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "生科系學生一生只夠開發一種藥  失敗人生就沒成就了", "push_ipdatetime": "02/21 15:23", "push_tag": "→", "push_userid": "jackliao1990"}, {"push_content": "台灣這些新藥股不就拿政府的錢去騙散戶 炒股價嗎?", "push_ipdatetime": "02/21 15:23", "push_tag": "→", "push_userid": "wuklean"}, {"push_content": "那我問你 生技除了炒股大賺 你覺得一個藥廠能養多", "push_ipdatetime": "02/21 15:23", "push_tag": "推", "push_userid": "wayne0218"}, {"push_content": "少人", "push_ipdatetime": "02/21 15:23", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "更何況台灣新藥公司都是在玩做藥 然後賣公司", "push_ipdatetime": "02/21 15:25", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "相關產業？可以舉個例子嗎 有啦 老闆炒股買車買房包", "push_ipdatetime": "02/21 15:25", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "小三", "push_ipdatetime": "02/21 15:25", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "你太樂觀了，就算研發成功好了，要怎麼跟國際大廠競", "push_ipdatetime": "02/21 15:26", "push_tag": "推", "push_userid": "gingsow"}, {"push_content": "爭？", "push_ipdatetime": "02/21 15:26", "push_tag": "→", "push_userid": "gingsow"}, {"push_content": "只有浩鼎研發免疫治療，其他大廠都在睡覺？", "push_ipdatetime": "02/21 15:27", "push_tag": "→", "push_userid": "gingsow"}, {"push_content": "燒肝跟產業沒關係  生技老闆就不會讓員工燒乾嗎？", "push_ipdatetime": "02/21 15:27", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "重點是勞工政策跟老闆心態 燒不燒肝跟產業有啥關聯", "push_ipdatetime": "02/21 15:28", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "科技業 製造業 服務業 哪個不血汗 難道你期待台灣", "push_ipdatetime": "02/21 15:28", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "老闆開生技公司 就突然不血汗嗎", "push_ipdatetime": "02/21 15:28", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "我看你才恨科技業老闆吧  生技業棒棒 科技業爛爛", "push_ipdatetime": "02/21 15:34", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "送你一句話 好工作是介紹來的 不是找來的", "push_ipdatetime": "02/21 15:35", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "沒實力讓人介紹爽工作 就不要抱怨燒肝", "push_ipdatetime": "02/21 15:35", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "原PO為啥認為生技不用熬夜?? 他們要睡LAB等結果", "push_ipdatetime": "02/21 15:36", "push_tag": "→", "push_userid": "jackliao1990"}, {"push_content": "原po知道現在國際大廠的產品線有幾個臨床實驗在做", "push_ipdatetime": "02/21 15:38", "push_tag": "推", "push_userid": "gingsow"}, {"push_content": "嗎", "push_ipdatetime": "02/21 15:38", "push_tag": "→", "push_userid": "gingsow"}, {"push_content": "還要守護培養中的細胞 要是被人亂碰 長黴 就GG了", "push_ipdatetime": "02/21 15:39", "push_tag": "噓", "push_userid": "wayne0218"}, {"push_content": "你從八卦版過來的吧 ？", "push_ipdatetime": "02/21 15:40", "push_tag": "噓", "push_userid": "soaringwings"}, {"push_content": "呵呵 那你可以去買蘋果股票啊 這樣就是 蘋果員工的", "push_ipdatetime": "02/21 15:41", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "老闆了", "push_ipdatetime": "02/21 15:41", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "要爭主導權也不是台灣新藥這種賣公司的手法", "push_ipdatetime": "02/21 15:43", "push_tag": "噓", "push_userid": "wayne0218"}, {"push_content": "講難聽點 這都是華爾街創投跟大藥廠轉嫁新藥研發風", "push_ipdatetime": "02/21 15:45", "push_tag": "推", "push_userid": "wayne0218"}, {"push_content": "險的商業手段", "push_ipdatetime": "02/21 15:45", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "來了來了 大絕來了 成熟點好不好", "push_ipdatetime": "02/21 15:47", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "發不發展不太重要就是了，股價震盪有錢賺，運氣差的", "push_ipdatetime": "02/21 15:50", "push_tag": "→", "push_userid": "tneduts"}, {"push_content": "技術不好的、聽新聞的、不懂愛買的送錢給贏家而已", "push_ipdatetime": "02/21 15:51", "push_tag": "→", "push_userid": "tneduts"}, {"push_content": "發展不會亡國，沒這麼偉大，同樣不發展也沒這麼嚴重", "push_ipdatetime": "02/21 15:55", "push_tag": "→", "push_userid": "tneduts"}, {"push_content": "不是業界核心人士或是相關技術人員不用太在意", "push_ipdatetime": "02/21 15:56", "push_tag": "→", "push_userid": "tneduts"}, {"push_content": "當然如果是這方面的專業人士要多注意些，這跟飯碗有", "push_ipdatetime": "02/21 15:57", "push_tag": "→", "push_userid": "tneduts"}, {"push_content": "這種發展方式真 只是淪為華爾街跟大藥廠用來分散研", "push_ipdatetime": "02/21 15:57", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "發風險的馬前卒而已 不是長久之計", "push_ipdatetime": "02/21 15:57", "push_tag": "→", "push_userid": "wayne0218"}, {"push_content": "關，就跟科技業陸資要併購時工程師會比較多意見", "push_ipdatetime": "02/21 15:58", "push_tag": "→", "push_userid": "tneduts"}, {"push_content": "我不是生技專家，但應該跟科技業研發有類似的感覺", "push_ipdatetime": "02/21 16:00", "push_tag": "→", "push_userid": "tneduts"}, {"push_content": "現在做硬體的真的沒以前好賺，也遇到一些轉型問題", "push_ipdatetime": "02/21 16:01", "push_tag": "→", "push_userid": "tneduts"}, {"push_content": "不過總會有人轉型成功，來來去去會有以前的巨人殞落", "push_ipdatetime": "02/21 16:02", "push_tag": "→", "push_userid": "tneduts"}, {"push_content": "總會有公司爆掉，也會有新公司產生，當然也有專門", "push_ipdatetime": "02/21 16:03", "push_tag": "→", "push_userid": "tneduts"}, {"push_content": "創立來炒股的公司，手法很多樣，股版論投資投機不用", "push_ipdatetime": "02/21 16:04", "push_tag": "→", "push_userid": "tneduts"}, {"push_content": "太在意這些就是了，至於國家發展就談更遠了...", "push_ipdatetime": "02/21 16:04", "push_tag": "→", "push_userid": "tneduts"}, {"push_content": "你知道浩鼎這次做的東西也是一種cost down的概念嗎", "push_ipdatetime": "02/21 16:24", "push_tag": "→", "push_userid": "bravejared"}, {"push_content": "？所以你確定生技業比科技業好？", "push_ipdatetime": "02/21 16:24", "push_tag": "→", "push_userid": "bravejared"}, {"push_content": "科科 台灣連一間向惠氏規模的藥商都沒有 跟人家玩研", "push_ipdatetime": "02/21 17:17", "push_tag": "→", "push_userid": "mokinased"}, {"push_content": "發新藥 真的在作夢 以台灣老闆的心態 怎麼可能...", "push_ipdatetime": "02/21 17:17", "push_tag": "→", "push_userid": "mokinased"}, {"push_content": "就是因為台灣產業跟政府資源少 才更不該壓單一產業", "push_ipdatetime": "02/21 17:38", "push_tag": "推", "push_userid": "jamupme"}, {"push_content": "尤其是成功機率極低的產業", "push_ipdatetime": "02/21 17:38", "push_tag": "→", "push_userid": "jamupme"}, {"push_content": "你如果像GOOGLE 亞馬遜錢多不怕燒 要怎麼玩隨你", "push_ipdatetime": "02/21 17:39", "push_tag": "→", "push_userid": "jamupme"}, {"push_content": "新藥不好做還有學名藥", "push_ipdatetime": "02/21 18:28", "push_tag": "推", "push_userid": "sychang0807"}, {"push_content": "燒錢研發我絕對支持，但是台灣新藥公司很多都是燒錢", "push_ipdatetime": "02/21 18:30", "push_tag": "推", "push_userid": "hegemon"}, {"push_content": "炒股吧？", "push_ipdatetime": "02/21 18:30", "push_tag": "→", "push_userid": "hegemon"}, {"push_content": "生技就算成功了，也只是一兩間，能養多少人？", "push_ipdatetime": "02/21 21:51", "push_tag": "噓", "push_userid": "alotofjeff"}, {"push_content": "裝睡的人真的叫不醒..", "push_ipdatetime": "02/21 21:52", "push_tag": "→", "push_userid": "bearian"}, {"push_content": "政府拿上百億納稅人的錢砸出一個成功的生技公司", "push_ipdatetime": "02/21 21:52", "push_tag": "→", "push_userid": "alotofjeff"}, {"push_content": "結果上下游養活不到一千人，了不起三千人，搞屁啊？", "push_ipdatetime": "02/21 21:53", "push_tag": "→", "push_userid": "alotofjeff"}, {"push_content": "而且讓財富更集中，貧富差距更大，這就是dpp的目標", "push_ipdatetime": "02/21 21:55", "push_tag": "→", "push_userid": "alotofjeff"}, {"push_content": "鬼島從窮人口袋掏錢最容易", "push_ipdatetime": "02/21 22:28", "push_tag": "噓", "push_userid": "soyghcg"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456038556.A.B0C.html"},
{"article_id": "M.1456038794.A.E07", "article_title": "Re: [新聞] 浩鼎乳癌新藥解盲　有利免疫抗體生成", "author": "zaizen (太陽研究社社長)", "board": "Stock", "content": "如果進到最後一階段 一顆藥物大概燒掉10億台幣 你說多是多 說少也是少 只是如果對於創業型公司 10億是很高的金額 而且成功率其實很低 反而如果有問題就不要繼續做下去 越早把計畫中止 剛好可以省一點錢 至於浩鼎還是看好的 背後的團隊是很強的 但是股價在還沒開發出新藥前 絕對不值目前的數字 所以修正是必然的事情 : 其實剛剛看大家一遍悲觀 : 還有人說因為很燒錢 : 所以台灣不該發展新藥 : 也不該發展生技 : 這種邏輯超怪的 : 只要研發有成有希望 燒掉的錢其實 : 並不是政府 外資也會投入 : 所以那些認為發展生技 : 台灣會因為燒錢而亡國的邏輯 : 真的是很無言 : 但在股版應該一堆人認為有理吧", "date": "Sun Feb 21 15:13:12 2016", "ip": "61.230.162.75", "message_count": {"all": 6, "boo": 0, "count": 2, "neutral": 4, "push": 2}, "messages": [{"push_content": "講廢話", "push_ipdatetime": "02/21 15:14", "push_tag": "→", "push_userid": "onok"}, {"push_content": "下看50", "push_ipdatetime": "02/21 15:14", "push_tag": "→", "push_userid": "onok"}, {"push_content": "10收", "push_ipdatetime": "02/21 15:14", "push_tag": "推", "push_userid": "tncshes86608"}, {"push_content": "需要一位台版的小保方晴子來拯救大家", "push_ipdatetime": "02/21 15:15", "push_tag": "推", "push_userid": "dahlia7357"}, {"push_content": "台版的小保方晴子...來毀滅台灣學術界公信力的嗎...", "push_ipdatetime": "02/21 16:11", "push_tag": "→", "push_userid": "ChallengerII"}, {"push_content": "小保方好像要洗白了", "push_ipdatetime": "02/21 20:52", "push_tag": "→", "push_userid": "guteres"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456038794.A.E07.html"},
{"article_id": "M.1456038890.A.B2C", "article_title": "[新聞] 浩鼎乳癌新藥解盲未過關 張念慈：沒有挫敗", "author": "featherb1ue (我愛我的小地瓜)", "board": "Stock", "content": "https://goo.gl/ 縮網址，連結能不能點擊者板規41處份。 3.心得/評論請盡量充實，心得過短將會以44一行文規範水桶處份。 4.請依格式輸入內容，未依格式者板規41砍文處份。 按ctrly可刪除以上內容。 1.原文連結(必須檢附)： http://www.chinatimes.com/realtimenews/20160221001926260410 2.原文內容： 浩鼎乳癌新藥OBI822今天宣布解盲，董事長張念慈說，這是一次成功的結果，有明確下 一步研究方向，比事先預期結果更好，但在用藥組與對照組相比，主要療效指標未呈現統 計學上顯著意義。 張念慈強調，此次結果，在無惡化存活期PFS有顯著改善，總體存活率（OS)也呈現正面趨 勢。 (工商即時) 3.心得/評論(必需填寫)： 這標題更扯... 記者會內容到底董事長講了什麼? 怎麼每個人解讀可以差這麼多? 有沒有人有錄音檔可以提供的 自己聽過才知道 ", "date": "Sun Feb 21 15:14:47 2016", "ip": "111.249.66.243", "message_count": {"all": 80, "boo": 7, "count": 33, "neutral": 33, "push": 40}, "messages": [{"push_content": "明天漲停", "push_ipdatetime": "02/21 15:15", "push_tag": "推", "push_userid": "g10"}, {"push_content": "...內鬨了", "push_ipdatetime": "02/21 15:15", "push_tag": "推", "push_userid": "WANG122122"}, {"push_content": "一個解盲，各自表述?", "push_ipdatetime": "02/21 15:16", "push_tag": "→", "push_userid": "bluefox0605"}, {"push_content": "應該是指藥品解盲這個活動成功，中文很微妙吧。XD", "push_ipdatetime": "02/21 15:16", "push_tag": "→", "push_userid": "abbei"}, {"push_content": "看明天股價反應就會知道了", "push_ipdatetime": "02/21 15:16", "push_tag": "推", "push_userid": "sad010"}, {"push_content": "你信這個嗎 派一個文組的改寫文章就能戰勝事實?", "push_ipdatetime": "02/21 15:17", "push_tag": "→", "push_userid": "dahlia7357"}, {"push_content": "無惡化存活期PFS數據就是成功與否的證明", "push_ipdatetime": "02/21 15:17", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "不用想太多。統計沒差異就是沒差異", "push_ipdatetime": "02/21 15:17", "push_tag": "推", "push_userid": "knownany"}, {"push_content": "如果真的有過 無惡化存活期PFS會說顯著良好", "push_ipdatetime": "02/21 15:17", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "哪是啥有改善...", "push_ipdatetime": "02/21 15:17", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "記住這記者名字 科科", "push_ipdatetime": "02/21 15:17", "push_tag": "→", "push_userid": "crazysinger"}, {"push_content": "先開發一個治療神經錯亂的藥好了", "push_ipdatetime": "02/21 15:18", "push_tag": "推", "push_userid": "casko"}, {"push_content": "什麼正面趨勢的說法。都是主觀上自我安慰", "push_ipdatetime": "02/21 15:18", "push_tag": "→", "push_userid": "knownany"}, {"push_content": "確實成功解盲 沒遭恐佈攻擊 沒柯賜海鬧場", "push_ipdatetime": "02/21 15:18", "push_tag": "推", "push_userid": "yilanism"}, {"push_content": "結果明天大跌2塊", "push_ipdatetime": "02/21 15:19", "push_tag": "推", "push_userid": "lovecut"}, {"push_content": "解盲記者會辦得很成功", "push_ipdatetime": "02/21 15:19", "push_tag": "→", "push_userid": "onok"}, {"push_content": "主要療效指標未呈現統計學上顯著意義", "push_ipdatetime": "02/21 15:19", "push_tag": "推", "push_userid": "gingsow"}, {"push_content": "重點只有這句，其他都廢話", "push_ipdatetime": "02/21 15:19", "push_tag": "→", "push_userid": "gingsow"}, {"push_content": "\"無惡化存活期PFS有顯著改善\" 應該算是大成功啊", "push_ipdatetime": "02/21 15:20", "push_tag": "推", "push_userid": "uyn"}, {"push_content": "\"療效指標未呈現統計學上顯著意義\" <--這個是失敗吧", "push_ipdatetime": "02/21 15:21", "push_tag": "→", "push_userid": "uyn"}, {"push_content": "一篇文章這樣寫讓人看不懂...", "push_ipdatetime": "02/21 15:21", "push_tag": "→", "push_userid": "uyn"}, {"push_content": "基本上就是失敗了 才會出來洗這樣的文", "push_ipdatetime": "02/21 15:21", "push_tag": "推", "push_userid": "sad010"}, {"push_content": "真的成功了 那文章就不是這樣寫了", "push_ipdatetime": "02/21 15:21", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "什麼正面趨勢...這種研究生寫論文的伎倆", "push_ipdatetime": "02/21 15:22", "push_tag": "推", "push_userid": "knownany"}, {"push_content": "想唬誰？", "push_ipdatetime": "02/21 15:22", "push_tag": "→", "push_userid": "knownany"}, {"push_content": "這有甚麼好疑惑的 你棒球輸給日本 但打得很好", "push_ipdatetime": "02/21 15:22", "push_tag": "推", "push_userid": "EasternAsh"}, {"push_content": "統計上沒有顯著差異代表....", "push_ipdatetime": "02/21 15:22", "push_tag": "推", "push_userid": "ben811018"}, {"push_content": "不要再自我安慰惹 這記者名字記一下 以後就能判斷", "push_ipdatetime": "02/21 15:22", "push_tag": "噓", "push_userid": "crazysinger"}, {"push_content": "那請問是輸了還是贏了?", "push_ipdatetime": "02/21 15:23", "push_tag": "→", "push_userid": "EasternAsh"}, {"push_content": "這整篇的結論很簡單兩個字 吃鍋貼", "push_ipdatetime": "02/21 15:23", "push_tag": "→", "push_userid": "EasternAsh"}, {"push_content": "了解了, 這記者寫法真的很爛...", "push_ipdatetime": "02/21 15:24", "push_tag": "推", "push_userid": "uyn"}, {"push_content": "6575心悅好像就是做精神病的藥", "push_ipdatetime": "02/21 15:24", "push_tag": "推", "push_userid": "fireda"}, {"push_content": "無惡化存活期PFS有顯著改善\"指的是有療效的病人有", "push_ipdatetime": "02/21 15:24", "push_tag": "推", "push_userid": "gingsow"}, {"push_content": "顯著改善", "push_ipdatetime": "02/21 15:24", "push_tag": "→", "push_userid": "gingsow"}, {"push_content": "但整體去分析就是失敗", "push_ipdatetime": "02/21 15:25", "push_tag": "→", "push_userid": "gingsow"}, {"push_content": "中時 杜X蓉", "push_ipdatetime": "02/21 15:25", "push_tag": "推", "push_userid": "needspace"}, {"push_content": "解盲成功拉 證實藥物失敗阿", "push_ipdatetime": "02/21 15:25", "push_tag": "→", "push_userid": "wuklean"}, {"push_content": "記者可能被套10張", "push_ipdatetime": "02/21 15:28", "push_tag": "噓", "push_userid": "angelaeric24"}, {"push_content": "新藥開發本來就一定是有點效用才會搞到這階段", "push_ipdatetime": "02/21 15:28", "push_tag": "推", "push_userid": "EasternAsh"}, {"push_content": "這標題意思可以解讀成 解盲的記者會成功完成", "push_ipdatetime": "02/21 15:29", "push_tag": "→", "push_userid": "EasternAsh"}, {"push_content": "意思是如果藥效有出現，就會有顯著改善，但有藥效出", "push_ipdatetime": "02/21 15:29", "push_tag": "推", "push_userid": "d147258"}, {"push_content": "現的機率不高，是這樣嗎？", "push_ipdatetime": "02/21 15:29", "push_tag": "→", "push_userid": "d147258"}, {"push_content": "這就是在玩中文巨型的容錯還有語意問題", "push_ipdatetime": "02/21 15:30", "push_tag": "→", "push_userid": "EasternAsh"}, {"push_content": "其實這種主動性藥物 無法去評斷是否是藥效有出現", "push_ipdatetime": "02/21 15:31", "push_tag": "推", "push_userid": "sad010"}, {"push_content": "因為他們主打的是\"激發\"自身免疫系統去抗癌", "push_ipdatetime": "02/21 15:31", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "但是自身免疫系統超乎預期發揮作用的時候", "push_ipdatetime": "02/21 15:32", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "可不一定是有給了甚麼樣的藥物", "push_ipdatetime": "02/21 15:32", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "所以他們能評斷的就是整體效用是否夠顯著", "push_ipdatetime": "02/21 15:32", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "代表這藥沒用，結案。", "push_ipdatetime": "02/21 15:34", "push_tag": "噓", "push_userid": "howard172"}, {"push_content": "記者文筆 + 大戶(or券商)意志 = 白癡在看的文章", "push_ipdatetime": "02/21 15:34", "push_tag": "→", "push_userid": "tsubasa"}, {"push_content": "原來如此", "push_ipdatetime": "02/21 15:34", "push_tag": "推", "push_userid": "d147258"}, {"push_content": "還是要等完整的數據才知道結果，或許可以比較Iressa", "push_ipdatetime": "02/21 15:36", "push_tag": "推", "push_userid": "gingsow"}, {"push_content": "的案例，次族群分析後另起一個臨床實驗", "push_ipdatetime": "02/21 15:36", "push_tag": "→", "push_userid": "gingsow"}, {"push_content": "P值不顯著耶 gg了", "push_ipdatetime": "02/21 15:36", "push_tag": "推", "push_userid": "b1izzard2000"}, {"push_content": "好股票 危G入市 讚", "push_ipdatetime": "02/21 15:37", "push_tag": "推", "push_userid": "Holihigh"}, {"push_content": "雖敗猶榮的意思", "push_ipdatetime": "02/21 15:45", "push_tag": "推", "push_userid": "slippers"}, {"push_content": "講白了 有學過統計都知道 未達顯著水準基本上就掰掰", "push_ipdatetime": "02/21 15:47", "push_tag": "推", "push_userid": "werqq"}, {"push_content": "過程成功 輸給自己", "push_ipdatetime": "02/21 15:57", "push_tag": "→", "push_userid": "eemail"}, {"push_content": "大學有念過初統的人都看得懂", "push_ipdatetime": "02/21 15:58", "push_tag": "推", "push_userid": "sdhpipt"}, {"push_content": "美國NBI跌到他媽都不認得了......", "push_ipdatetime": "02/21 16:03", "push_tag": "推", "push_userid": "transcend789"}, {"push_content": "師爺翻譯翻譯:這是坨屎，屎也是有用的，可以當肥料", "push_ipdatetime": "02/21 16:06", "push_tag": "推", "push_userid": "frank111"}, {"push_content": "統計上沒意義 就可以吃屎了", "push_ipdatetime": "02/21 16:11", "push_tag": "噓", "push_userid": "cliff159357"}, {"push_content": "利空出盡 噴", "push_ipdatetime": "02/21 16:12", "push_tag": "推", "push_userid": "Holihigh"}, {"push_content": "和棒球年年上演的雖敗猶榮一樣", "push_ipdatetime": "02/21 16:14", "push_tag": "推", "push_userid": "rjie"}, {"push_content": "記者都認錯改標題了，不要再鞭他了", "push_ipdatetime": "02/21 16:23", "push_tag": "推", "push_userid": "RiseFortune"}, {"push_content": "騙笑耶", "push_ipdatetime": "02/21 16:46", "push_tag": "推", "push_userid": "rickcoo"}, {"push_content": "記者改標題了耶", "push_ipdatetime": "02/21 16:57", "push_tag": "推", "push_userid": "scratch01"}, {"push_content": "改成：浩鼎乳癌新藥解盲未過關 張念慈：沒有挫敗", "push_ipdatetime": "02/21 17:03", "push_tag": "推", "push_userid": "kof70380"}, {"push_content": "原PO應該要改標題 不能誤導別人", "push_ipdatetime": "02/21 17:03", "push_tag": "→", "push_userid": "kof70380"}, {"push_content": "公司派來發文的嗎 版主這要管一下吧 誤導人", "push_ipdatetime": "02/21 17:16", "push_tag": "推", "push_userid": "CTC0115"}, {"push_content": "樓上 這是原本記者的發文標題 只是記者後來改標題了", "push_ipdatetime": "02/21 17:18", "push_tag": "→", "push_userid": "scratch01"}, {"push_content": "原PO用這個標題,真有膽,不怕被告嗎", "push_ipdatetime": "02/21 17:57", "push_tag": "噓", "push_userid": "fotumbra"}, {"push_content": "跟原PO無關 一開始轉載是此標題 但是建議改掉", "push_ipdatetime": "02/21 17:58", "push_tag": "推", "push_userid": "dahlia7357"}, {"push_content": "浩鼎乳癌新藥解盲未過關 張念慈：沒有挫敗，不改標", "push_ipdatetime": "02/21 18:13", "push_tag": "噓", "push_userid": "morelife"}, {"push_content": "題嗎？", "push_ipdatetime": "02/21 18:13", "push_tag": "→", "push_userid": "morelife"}, {"push_content": "成功解盲 =/= 解盲成功", "push_ipdatetime": "02/21 18:40", "push_tag": "→", "push_userid": "TouSan"}, {"push_content": "解盲還會有失敗的嗎？？？？？", "push_ipdatetime": "02/21 18:56", "push_tag": "推", "push_userid": "cyora"}, {"push_content": "幹你媽什麼標題", "push_ipdatetime": "02/21 21:26", "push_tag": "噓", "push_userid": "wakauo"}, {"push_content": "原PO真無辜", "push_ipdatetime": "02/21 21:51", "push_tag": "推", "push_userid": "beggerchou"}, {"push_content": "雖敗猶榮. 加油. 失敗為成功之母...", "push_ipdatetime": "02/21 22:41", "push_tag": "推", "push_userid": "kkchen"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456038890.A.B2C.html"},
{"article_id": "M.1456038956.A.37A", "article_title": "Re: [標的] 4714 浩鼎", "author": "OriginStar ()", "board": "Stock", "content": "好啦，好啦，沒過就算了，還有中裕(誤) 生技股我只敢買具有實質獲利的藥廠(學名藥)，來回操作其實也獲利不少 專業的應該要先看這個吧 https://clinicaltrials.gov/show/NCT01516307 看不懂沒關係，因為我也看不懂 我只是希望到時不要像基亞一樣，主力被金主斷頭，把一些不相關的股票 也送作堆 昨天我查了一下浩鼎網站 http://www.obipharma.com/index.aspx?lang=chifn=pipeline_contentno=4 乳癌是女性中最常見的癌症，轉移性乳癌五年存活率不到24.3% ；台灣浩鼎自 美國Memorial SloanKettering Cancer Center (MSKCC)單獨技轉OBI822，並將 Globo H連接至KLH，發展OBI822為第一個針對轉移式乳癌的主動式免疫療法， 希望藉此提供尚乏有效治療的醫療需求(Unmet medical needs)。 然後再查 台灣浩鼎於2002年成立，初為美國上市公司Optimer Pharmaceuticals在台百分 之百投資的子公司，2012年5月15日經行政院金融監督管理委員會證券期貨局核 准成為公開發行公司(證券代號：4174)， 2012年12月12日登錄興櫃，而於2015 年3月23日正式掛牌上櫃。 Optimer Pharmaceuticals ==> Cubist Pharmaceuticals Inc ==> Merck Co 先不談技轉，研發新藥看來真的蠻燒錢的，無法繼續會去的就只好合併或被併購 : : 1.發文前請先詳閱[標的]分類發文規範，未依規範發文將受處份。 : 2.發標的文未充實內文，多空理由不充實者，板規41或44處份 : 3.退場機制未說明價位、出場條件或長期投資，並敘述對應之理由者，板規41 : 4.請依格式輸入內容，未依格式者板規41砍文處份。 : 5.分類選填請益或心得者，進退場機制得刪去。 : 按ctrly可刪除以上內容。 : 1. 標的：4174 : 2. 分類：多 : 3. 分析/正文： : 等這麼久，終於等到浩鼎解盲這一天，對於浩鼎藥不夠了解的人，可以先看這支影片 : http://tinyurl.com/hhgvnpk : 今年浩鼎有兩個重要時間，一個就是今天，一個是六月的ASCO。 : 今天浩鼎解盲公告後會召開妓者會，其實我估算PFS，應該是已經過了台灣三期條件， : 解盲後也只有一些簡單的資訊揭露，今天最重要的重點，是浩鼎有沒有要參加今年六月 : 的ASCO大會，如果要參加，現在就要準備將台灣這次三期資料彙整送交ASCO，只要有 : 報名參加ASCO，那代表數據一定很棒，不然不可能上台，就算上台也是丟臉而已， : 如果可以參加ASCO就會吸引國際目光，今天只是第一階段，通過台灣三期臨床，申請 : 藥證。 : 4. 進退場機制:今天解盲不好，明天就賣 http://www.flickr.com/photos/originstar/", "date": "Sun Feb 21 15:15:51 2016", "ip": "59.122.243.90", "message_count": {"all": 4, "boo": 0, "count": 0, "neutral": 4, "push": 0}, "messages": [{"push_content": "很納悶這種還沒有獲利的公司竟然會被MSCI列入成份股", "push_ipdatetime": "02/21 15:32", "push_tag": "→", "push_userid": "erotic"}, {"push_content": "反正做金融業的只需懂股價高就是好股票  不需懂製藥", "push_ipdatetime": "02/21 15:38", "push_tag": "→", "push_userid": "tsubasa"}, {"push_content": "代修標題", "push_ipdatetime": "02/21 20:02", "push_tag": "→", "push_userid": "IanLi"}, {"push_content": "接下來就是炒高讓大戶倒貨 散戶追高接著就解散下市", "push_ipdatetime": "02/21 20:28", "push_tag": "→", "push_userid": "sonatafm2"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456038956.A.37A.html"},
{"article_id": "M.1456038962.A.FE8", "article_title": "Re: [新聞] 浩鼎乳癌新藥解盲　有利免疫抗體生成", "author": "a467455 (我愛主播)", "board": "Stock", "content": "有沒有強者說明一下 當時基亞解盲沒過的時候 基亞殺好幾個跌停 當時其他的生技股 都是隨者基亞這樣強殺嗎 剛剛看了財報 有些生技股 其實財報都不錯 像是 1789的神隆 4105的東洋 這兩支生技股 根本就是生技界的GG 營收成長 業績成長 不像其他生技股 只能靠本夢比 有沒有強者敘述一下 當時解盲沒過 是所有生技股都大殺嗎 ", "date": "Sun Feb 21 15:16:00 2016", "ip": "114.40.91.145", "message_count": {"all": 37, "boo": 1, "count": 16, "neutral": 19, "push": 17}, "messages": [{"push_content": "東洋就算了...神隆你認真?", "push_ipdatetime": "02/21 15:17", "push_tag": "→", "push_userid": "shihchinlun"}, {"push_content": "基亞就那顆肝癌藥抄上天，特異功能沒了當然強殺。", "push_ipdatetime": "02/21 15:17", "push_tag": "→", "push_userid": "abbei"}, {"push_content": "蘋果手機賣不好，你會去買三星，然後說世界需求高", "push_ipdatetime": "02/21 15:18", "push_tag": "推", "push_userid": "tncshes86608"}, {"push_content": "嗎", "push_ipdatetime": "02/21 15:18", "push_tag": "→", "push_userid": "tncshes86608"}, {"push_content": "你去看生計指數", "push_ipdatetime": "02/21 15:18", "push_tag": "推", "push_userid": "WANG122122"}, {"push_content": "一起殺啦 你別小看投資人的恐慌和失落", "push_ipdatetime": "02/21 15:18", "push_tag": "→", "push_userid": "dahlia7357"}, {"push_content": "禮拜四生技一起漲難道是大家的藥突然都成功了", "push_ipdatetime": "02/21 15:19", "push_tag": "→", "push_userid": "dahlia7357"}, {"push_content": "孩子  把股票線圖拉出來就有答案  這不是基本功嗎?", "push_ipdatetime": "02/21 15:19", "push_tag": "推", "push_userid": "IanLi"}, {"push_content": "20140725殺到20140818", "push_ipdatetime": "02/21 15:20", "push_tag": "推", "push_userid": "WANG122122"}, {"push_content": "你神隆是哪時財報??", "push_ipdatetime": "02/21 15:22", "push_tag": "推", "push_userid": "small91051"}, {"push_content": "沒錯 不分青紅皂白全殺 一個月內OTC生技指數掉三成", "push_ipdatetime": "02/21 15:23", "push_tag": "推", "push_userid": "vg175"}, {"push_content": "絕對不分青紅皂白生技開盤跳空5% 這樣已經算溫和了", "push_ipdatetime": "02/21 15:24", "push_tag": "推", "push_userid": "dahlia7357"}, {"push_content": "基亞就算了 今天是浩鼎！龍頭殺大家絕對一起見骨", "push_ipdatetime": "02/21 15:25", "push_tag": "→", "push_userid": "dahlia7357"}, {"push_content": "那上市呢", "push_ipdatetime": "02/21 15:26", "push_tag": "推", "push_userid": "u770114"}, {"push_content": "只能看有沒有神秘的資金能讓他提前在5跟以內被拉回", "push_ipdatetime": "02/21 15:26", "push_tag": "→", "push_userid": "dahlia7357"}, {"push_content": "沒錯 這是撿績優生技股的最佳時機", "push_ipdatetime": "02/21 15:27", "push_tag": "推", "push_userid": "soaringwings"}, {"push_content": "沒錯 這時候就是找有穿內褲的來進場", "push_ipdatetime": "02/21 15:27", "push_tag": "→", "push_userid": "dahlia7357"}, {"push_content": "當時明明就是大盤也壓回,上櫃電子也跌 別說的好像", "push_ipdatetime": "02/21 15:28", "push_tag": "推", "push_userid": "cloud701002"}, {"push_content": "只有生技在跌,生技只是跌比較重而已", "push_ipdatetime": "02/21 15:29", "push_tag": "→", "push_userid": "cloud701002"}, {"push_content": "當時東洋一個月-30%", "push_ipdatetime": "02/21 15:33", "push_tag": "→", "push_userid": "soaringwings"}, {"push_content": ".....", "push_ipdatetime": "02/21 15:54", "push_tag": "噓", "push_userid": "gagagu"}, {"push_content": "真的不可取哎哎", "push_ipdatetime": "02/21 15:54", "push_tag": "→", "push_userid": "gagagu"}, {"push_content": "若浩鼎真的失敗，市場和公司派資金和資源反而能全", "push_ipdatetime": "02/21 16:04", "push_tag": "推", "push_userid": "sun613"}, {"push_content": "面轉往中裕，雖明天開盤生技會殺低，但賣了浩鼎的", "push_ipdatetime": "02/21 16:04", "push_tag": "→", "push_userid": "sun613"}, {"push_content": "資金午盤後很可能會轉往拉抬中裕！", "push_ipdatetime": "02/21 16:04", "push_tag": "→", "push_userid": "sun613"}, {"push_content": "= = 一檔被套怎麼會把錢再拿去給另外一檔套", "push_ipdatetime": "02/21 16:08", "push_tag": "推", "push_userid": "dahlia7357"}, {"push_content": "浩呆要撐住阿  拚5根跌停打開", "push_ipdatetime": "02/21 16:12", "push_tag": "推", "push_userid": "soaringwings"}, {"push_content": "東洋是換董事長宣告公司沒賺錢他不支薪股價才回升", "push_ipdatetime": "02/21 16:14", "push_tag": "推", "push_userid": "chen5512"}, {"push_content": "資金會跑去拉其他檔....這麼樂觀！可以不要害人嗎？", "push_ipdatetime": "02/21 16:15", "push_tag": "推", "push_userid": "bearian"}, {"push_content": "我的解讀是中裕的資金跑掉去拉非生技類的", "push_ipdatetime": "02/21 16:16", "push_tag": "→", "push_userid": "dahlia7357"}, {"push_content": "中裕可以不用陪葬 但是短期沒有拉這檔的意義啊", "push_ipdatetime": "02/21 16:17", "push_tag": "→", "push_userid": "dahlia7357"}, {"push_content": "推大江", "push_ipdatetime": "02/21 18:05", "push_tag": "推", "push_userid": "aboveground"}, {"push_content": "每次大跌都會出現資金轉移這種自我安慰的想法", "push_ipdatetime": "02/21 18:06", "push_tag": "推", "push_userid": "False"}, {"push_content": "看太多次這種言論了 都馬是一起跌", "push_ipdatetime": "02/21 18:07", "push_tag": "→", "push_userid": "False"}, {"push_content": "從來沒有過什麼大跌然後資金轉移這種事", "push_ipdatetime": "02/21 18:07", "push_tag": "→", "push_userid": "False"}, {"push_content": "頂多是跌多跌少 重災區與受波及輕災區而已而已", "push_ipdatetime": "02/21 18:08", "push_tag": "→", "push_userid": "False"}, {"push_content": "最好資金拉別檔 錢太多嗎", "push_ipdatetime": "02/21 19:04", "push_tag": "→", "push_userid": "zxc78951"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456038962.A.FE8.html"},
{"article_id": "M.1456039121.A.CAB", "article_title": "Re: [新聞] 浩鼎乳癌新藥解盲　有利免疫抗體生成", "author": "lackture (靜心、盡心)", "board": "Stock", "content": ": 引述《BAINE (請愛平頭男)》之銘言： : 有沒有強者說明一下 當時基亞解盲沒過的時候 基亞殺好幾個跌停 : 當時其他的生技股 都是隨者基亞這樣強殺嗎 : 剛剛看了財報 有些生技股 其實財報都不錯 : 像是 1789的神隆 4105的東洋 這兩支生技股 根本就是生技界的GG : 營收成長 業績成長 不像其他生技股 只能靠本夢比 : 有沒有強者敘述一下 當時解盲沒過 是所有生技股都大殺嗎 年前有看過一篇文章，和大家分享一下 對現時台股投資來說觀念頗中肯的 轉載自萬寶周刊臉書 https://www.facebook.com/marboweekly/ 萬寶週刊 1月29日 22:16 台北市 新藥股的賭石投資理論 連寫了幾天的生技股 可能有人認為我很不看好生技 但適得其反 我一直很認為台灣要發展生技這類的高附加價值的產業 就如同當年我去拜訪智擎(4162)葉常菁總經理的感想 13個人怎麼創造350億的市值 看來就只有生技了 因此我才特別在當時做了一本生技特刊 將台灣股價在50元以上的公司幾乎都專訪一遍 但現在為什麼有時投資人會認為我站在相對保守的一方呢 因為每家公司的確都很兢兢業業的在經營 大家也都希望有好的成果 但有時在股價過熱或是高估的時候 的確很容易造成投資人的受傷 畢竟高報酬一定隱含著高風險 怎麼分析過熱呢 記得三年前我在做生技專刊的時候 跟投資人提到505(b)(2)或是特殊學名藥的時候 大家都點頭如搗蒜 像是吸收新知樣 但現在大家都對這些名詞朗朗上口 卻對它隱含的意義似懂非懂 這就好像擦鞋童理論一樣 才是最恐怖的 那到底怎麼評斷新藥股的價值呢 一般普遍被認同的方法 就是計算每顆藥能夠創造的總市值 就是公司未來可以達到的價值 看似公平簡單明瞭 但就是所有的變數皆不可知 成功的比例要推估 成功後奪取市場的比例要推估 藥價要推估 有沒有後續競爭者要推估 在那麼多不可知的變因下 那創造的總市值 變成只有研究報告上的數字意義 想推薦就把變數調高一點 想降評就把變數調低一點 因為算出來的數字從來不準 所以到底要怎麼投資呢 我過去提出一個有趣的想法 叫做賭石理論 我們知道在中國賭石一度甚為流行 拿到玉石礦區的一個石頭 就開始抽絲剝繭推測市價 一開始只看外表的石紋 這就好像0期或是IND的時候 只看題目就要決生死 當然一般人不會想賭 想賭也是相當低價 所以就有人會開始敲敲打打 如果因此看到雜質或是根本非玉 那就失敗了 但如果開始看到碧綠的部份 就像實驗到一期 就有人開始待價而沽了 當然如果更有信心的人 就繼續琢磨看到石頭內涵更多的部份 失敗就一切歸零 成功價格又開始三級跳 那什麼時候是賭石的人最好放手利潤最大的機會呢 我認為絕不是把它全部看清 因為要把他看清 就是一翻兩瞪眼 它有以下幾種可能 第一完全失敗 那就可能跟基亞(3176)一樣 從天堂到地獄 第二即使成功 但表現不如預期 例如寶齡(1760) 商品開始販賣候不管是銷售或是分紅都 不如預期 第三是雖然大賣 但股價已經充分反映甚至過份反映 就像現在的浩鼎(4174)與中裕(4147) 我相信目前市場的價值都已經反映他們必過 而且還要大賣 當然我們也十分祝福他們可以成為台灣之光 但即使真的過關 還要賣的動賣的合乎預期 這又是另一個故事了 所以真正聰明的人 會去賭這顆石頭到最後嗎 我只能說投資人越來越聰明了 這次大選前大家都認為中裕是蔡英文概念股吧 但當選當天中裕有漲嗎 是漲在前面吧 股市永遠是領先預期 真的可以抱著越久領的越久並不容易 否則台積電就不會那麼的有價值了 聰明的你抱著新藥股 什麼時候是你獲利的最高峰 看著賭石的人什麼時候賣出的邏輯 就可以看出一二了 心視界 http://newheartsight.blogspot.tw/ 詹姆士的財經新聞頻道 https://www.facebook.com/knowmorefin/", "date": "Sun Feb 21 15:18:37 2016", "ip": "36.238.69.44", "message_count": {"all": 5, "boo": 0, "count": 5, "neutral": 0, "push": 5}, "messages": [{"push_content": "這篇中肯，研發成功一回事，能否獲利又是另一回事", "push_ipdatetime": "02/21 15:30", "push_tag": "推", "push_userid": "gingsow"}, {"push_content": "~新藥會不會成功不是重點~重點是聽成功消息買的人慘", "push_ipdatetime": "02/21 15:41", "push_tag": "推", "push_userid": "ericcyc0194"}, {"push_content": "這篇很好", "push_ipdatetime": "02/21 16:24", "push_tag": "推", "push_userid": "pedro501"}, {"push_content": "管你獲不獲利，在鬼島有題材就是要吵", "push_ipdatetime": "02/21 16:57", "push_tag": "推", "push_userid": "DarkBuster"}, {"push_content": "簡言之 就是不管成功與否 去抓股價獲利的期待值", "push_ipdatetime": "02/21 17:24", "push_tag": "推", "push_userid": "EasternAsh"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456039121.A.CAB.html"},
{"article_id": "M.1456039854.A.DA4", "article_title": "[新聞] 浩鼎將變更設計 擴大三期臨床試驗", "author": "ncaa8702 (穎　川　衍　派)", "board": "Stock", "content": "1.原文連結(必須檢附)： http://udn.com/news/story/6/1515374%E6%B5%A9%E9%BC%8E%E5%B0%87%E8%AE%8A%E6%9B%B4%E8%A8%AD%E8%A8%88%E6%93%B4%E5%A4%A7%E4%B8%89%E6%9C%9F%E8%87%A8%E5%BA%8A%E8%A9%A6%E9%A9%97 2.原文內容：20160221 14:54 經濟日報 記者高行即時報導 針對浩鼎抗乳癌新藥OBI822後續發展，董事長張念慈表示，此次解盲儘管未達標，但後 續仍將和台灣食衛署討論申請藥證的後續事宜，且有鑑於此次解盲相關數據已證明IgG、 IgM免疫抗體反應機制效應，現正朝第三期臨床試驗設計，主要在美、歐進行，將擴大全 球臨床試驗人數。 OBI822多國臨床試驗計畫總主持人黃俊升指出，解盲初步結果顯示，OBI822能讓產生免 疫反應的患者獲得非常顯著的益處，研究團隊相當振奮，將進一步以前期實驗結果為依據 ，重新設計第三期臨床試驗，以有無產生免疫反應為主要標準，有效降低第三期臨床試驗 的風險。 黃俊升指出，如果按照目前第三期臨床設計規畫，以有無免疫反應作為新設計指標，若套 在這次解盲結果應該已過關，且法規單位對新指標的接受度也高，加上試驗結果的用 藥安全性不錯，對後續第三期臨床試驗的結果仍抱持樂觀。 3.心得/評論(必需填寫)：國英數物理化學生物 六科不能上台大醫 取國英數 三科來上台大財金? ", "date": "Sun Feb 21 15:30:52 2016", "ip": "111.240.148.221", "message_count": {"all": 73, "boo": 4, "count": 27, "neutral": 38, "push": 31}, "messages": [{"push_content": "凹一下 繼續炒股", "push_ipdatetime": "02/21 15:32", "push_tag": "→", "push_userid": "crazysinger"}, {"push_content": "評論真有趣", "push_ipdatetime": "02/21 15:32", "push_tag": "推", "push_userid": "MaInNine"}, {"push_content": "看來就是不死心...繼續在大幅的坑散戶吧", "push_ipdatetime": "02/21 15:33", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "搞不好 明天漲停 3月破千 4月股王", "push_ipdatetime": "02/21 15:33", "push_tag": "推", "push_userid": "g10"}, {"push_content": "翻譯  給我錢繼續炒", "push_ipdatetime": "02/21 15:34", "push_tag": "→", "push_userid": "wuklean"}, {"push_content": "找檯階下,不然會很沒面子...", "push_ipdatetime": "02/21 15:34", "push_tag": "→", "push_userid": "erotic"}, {"push_content": "用google縮一下網址吧", "push_ipdatetime": "02/21 15:34", "push_tag": "→", "push_userid": "soaringwings"}, {"push_content": "明天開低走高.....", "push_ipdatetime": "02/21 15:35", "push_tag": "→", "push_userid": "poru"}, {"push_content": "誰能找當初基亞硬凹的發言出來比一下", "push_ipdatetime": "02/21 15:36", "push_tag": "→", "push_userid": "dahlia7357"}, {"push_content": "看到硬奶耶", "push_ipdatetime": "02/21 15:36", "push_tag": "推", "push_userid": "cindycincia"}, {"push_content": "這不就是傳說的雖然很可惜 但也別太擔心XX", "push_ipdatetime": "02/21 15:37", "push_tag": "→", "push_userid": "dahlia7357"}, {"push_content": "這樣評論有失公平", "push_ipdatetime": "02/21 15:37", "push_tag": "推", "push_userid": "green26"}, {"push_content": "癌症太複雜了，抗藥性很快出現，癌症藥只是個夢", "push_ipdatetime": "02/21 15:37", "push_tag": "推", "push_userid": "hamel"}, {"push_content": "雖敗遊龍 再接再厲", "push_ipdatetime": "02/21 15:38", "push_tag": "推", "push_userid": "fireda"}, {"push_content": "四海遊龍", "push_ipdatetime": "02/21 15:39", "push_tag": "→", "push_userid": "abbei"}, {"push_content": "真的 說不定人家本來就只準備國英數", "push_ipdatetime": "02/21 15:39", "push_tag": "推", "push_userid": "MaInNine"}, {"push_content": "哇~~原來原始命題效果不顯著", "push_ipdatetime": "02/21 15:40", "push_tag": "推", "push_userid": "sad010"}, {"push_content": "所以換個命題繼續炒就算顯著", "push_ipdatetime": "02/21 15:40", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "這樣的公司是炒股用的吧? 真的是想研發啥新藥", "push_ipdatetime": "02/21 15:40", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "一次失敗不算失敗  繼續", "push_ipdatetime": "02/21 15:41", "push_tag": "推", "push_userid": "goddarn"}, {"push_content": "連記者都在護航 搞不好明天不跌反漲 主力很強", "push_ipdatetime": "02/21 15:41", "push_tag": "推", "push_userid": "g10"}, {"push_content": "怎麼有的說成功?有的說失敗?都沒人敢q&a到底是什麼", "push_ipdatetime": "02/21 15:42", "push_tag": "推", "push_userid": "ntunick"}, {"push_content": "？", "push_ipdatetime": "02/21 15:42", "push_tag": "→", "push_userid": "ntunick"}, {"push_content": "沒出點消息洗一下水 那些有錢有勢的\"主力\"怎麼出貨", "push_ipdatetime": "02/21 15:43", "push_tag": "推", "push_userid": "sad010"}, {"push_content": "明天硬洗到沒跌停 等主力要出貨的時候就...", "push_ipdatetime": "02/21 15:43", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "意思是只對部分病人有效的意思嗎？", "push_ipdatetime": "02/21 15:43", "push_tag": "→", "push_userid": "lflin"}, {"push_content": "就算三期的假設是藥能產生免疫反應 不代表免疫反應", "push_ipdatetime": "02/21 15:44", "push_tag": "→", "push_userid": "peter193991"}, {"push_content": "跟治療癌症有關啊", "push_ipdatetime": "02/21 15:44", "push_tag": "→", "push_userid": "peter193991"}, {"push_content": "看黑人白人會不會復發病例少一點", "push_ipdatetime": "02/21 15:44", "push_tag": "噓", "push_userid": "au4au4j3fu4"}, {"push_content": "這次不一樣 主力強 3~4根很多 就像宏達電 還有70多", "push_ipdatetime": "02/21 15:44", "push_tag": "推", "push_userid": "g10"}, {"push_content": "誰有學過實驗設計", "push_ipdatetime": "02/21 15:46", "push_tag": "推", "push_userid": "genius721105"}, {"push_content": "跟雞鴨一模一樣，沒過還說一些543的，看現在雞鴨的", "push_ipdatetime": "02/21 15:46", "push_tag": "推", "push_userid": "evil7589"}, {"push_content": "股價就知道了，承認失敗很難嗎？", "push_ipdatetime": "02/21 15:46", "push_tag": "→", "push_userid": "evil7589"}, {"push_content": "大家論文還不是換了多種統計方法才過關的", "push_ipdatetime": "02/21 15:47", "push_tag": "→", "push_userid": "genius721105"}, {"push_content": "試驗失敗，但有學術意義，結案", "push_ipdatetime": "02/21 15:47", "push_tag": "推", "push_userid": "gingsow"}, {"push_content": "口試後才改論文目的就要延畢至少半年了QQ", "push_ipdatetime": "02/21 15:48", "push_tag": "→", "push_userid": "abbei"}, {"push_content": "所以改玩命題 主要療效從乳癌變成有免疫反應?", "push_ipdatetime": "02/21 15:48", "push_tag": "推", "push_userid": "sad010"}, {"push_content": "這樣說啥是要想為台灣盡一份力 純炒股的嘛", "push_ipdatetime": "02/21 15:49", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "學術有意義但對股價沒意義 600太高了300還差不多", "push_ipdatetime": "02/21 15:49", "push_tag": "推", "push_userid": "dahlia7357"}, {"push_content": "股價700,真的很扯", "push_ipdatetime": "02/21 15:50", "push_tag": "噓", "push_userid": "Daikin"}, {"push_content": "重點在 大戶想在多少元把他接起來才是重點", "push_ipdatetime": "02/21 15:51", "push_tag": "推", "push_userid": "dahlia7357"}, {"push_content": "該試驗設計很常見，不用想太多", "push_ipdatetime": "02/21 15:51", "push_tag": "推", "push_userid": "gingsow"}, {"push_content": "剩下的完全跟試驗無關 而是有錢人怎麼玩它", "push_ipdatetime": "02/21 15:52", "push_tag": "→", "push_userid": "dahlia7357"}, {"push_content": "我猜 最多跌到250", "push_ipdatetime": "02/21 15:52", "push_tag": "推", "push_userid": "Granadilla"}, {"push_content": "我是有錢人現在不會把錢砸在半年不動的股票", "push_ipdatetime": "02/21 15:52", "push_tag": "→", "push_userid": "dahlia7357"}, {"push_content": "一堆OTC股價兩週漲30% 現在誰跟你玩買了求不跌", "push_ipdatetime": "02/21 15:53", "push_tag": "→", "push_userid": "dahlia7357"}, {"push_content": "炒別檔也許兩週就有15%績效了", "push_ipdatetime": "02/21 15:54", "push_tag": "→", "push_userid": "dahlia7357"}, {"push_content": "看這次的主力要怎麼出貨吧 如果眾人覺得主力夠有力", "push_ipdatetime": "02/21 15:54", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "說不定短時間不會這麼慘...但是主力也要逃的時候...", "push_ipdatetime": "02/21 15:55", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "一些小型OTC營收創新高 不就等同浩鼎解盲成功", "push_ipdatetime": "02/21 15:55", "push_tag": "→", "push_userid": "dahlia7357"}, {"push_content": "基亞跌到180有開過一次 身為受害者記得很清楚Orz", "push_ipdatetime": "02/21 15:56", "push_tag": "推", "push_userid": "vg175"}, {"push_content": "要討論浩鼎的技術進出只有它解盲成功才有意義", "push_ipdatetime": "02/21 15:56", "push_tag": "→", "push_userid": "dahlia7357"}, {"push_content": "請記住買股票的原因是因為他一直在漲 而不是跌", "push_ipdatetime": "02/21 15:57", "push_tag": "→", "push_userid": "dahlia7357"}, {"push_content": "一直放一些似是而非的論點...看來很怕被套半個月..", "push_ipdatetime": "02/21 16:03", "push_tag": "→", "push_userid": "yoluyolu"}, {"push_content": "崩定了", "push_ipdatetime": "02/21 16:04", "push_tag": "推", "push_userid": "hamel"}, {"push_content": "要漲停了!!", "push_ipdatetime": "02/21 16:05", "push_tag": "推", "push_userid": "recollective"}, {"push_content": "作者評論很好 達標要醫學系 你上藥學系就是沒用", "push_ipdatetime": "02/21 16:12", "push_tag": "推", "push_userid": "predominant"}, {"push_content": "趕快買哦！不然買不到會槌心肝～", "push_ipdatetime": "02/21 16:12", "push_tag": "推", "push_userid": "bearian"}, {"push_content": "還記得某雜誌封面：你敢不敢賭？", "push_ipdatetime": "02/21 16:20", "push_tag": "推", "push_userid": "transcend789"}, {"push_content": "翻譯：繼續給我錢炒股", "push_ipdatetime": "02/21 16:24", "push_tag": "→", "push_userid": "Boyzone"}, {"push_content": "要鎖死了", "push_ipdatetime": "02/21 16:28", "push_tag": "推", "push_userid": "mune"}, {"push_content": "yo可以撿便宜囉 大家恐懼 要貪婪阿", "push_ipdatetime": "02/21 17:00", "push_tag": "推", "push_userid": "Holihigh"}, {"push_content": "攤平攤到10元就對了", "push_ipdatetime": "02/21 17:05", "push_tag": "推", "push_userid": "aquahau"}, {"push_content": "50元收一張", "push_ipdatetime": "02/21 18:09", "push_tag": "推", "push_userid": "ftrain"}, {"push_content": "幾4根跌停就沒機會了，別幻想記者會買到漲停", "push_ipdatetime": "02/21 18:16", "push_tag": "噓", "push_userid": "morelife"}, {"push_content": "記者肯定買一堆，只要跌停必死無疑。", "push_ipdatetime": "02/21 18:17", "push_tag": "→", "push_userid": "morelife"}, {"push_content": "怎麼上去怎麼下來。", "push_ipdatetime": "02/21 18:18", "push_tag": "→", "push_userid": "morelife"}, {"push_content": "壞了50收 可兌換天堂遊戲幣", "push_ipdatetime": "02/21 18:20", "push_tag": "→", "push_userid": "Xenosaga"}, {"push_content": "當試圖將一件事以複雜的方式來解釋》不想簡單的說", "push_ipdatetime": "02/21 18:35", "push_tag": "→", "push_userid": "jones2011"}, {"push_content": "沒過就是沒過 硬凹想繼續騙人進場買股= =?", "push_ipdatetime": "02/21 19:20", "push_tag": "→", "push_userid": "wildwoof"}, {"push_content": "一堆人還是硬凹看漲，算了，裝睡的人真的叫不醒..", "push_ipdatetime": "02/21 21:52", "push_tag": "→", "push_userid": "bearian"}, {"push_content": "感覺有陰毛論，結果第三期過，大股東通吃", "push_ipdatetime": "02/21 22:32", "push_tag": "噓", "push_userid": "soyghcg"}, {"push_content": "有上台大就好 醫科和財金沒關係", "push_ipdatetime": "02/22 00:21", "push_tag": "→", "push_userid": "SweetLee"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456039854.A.DA4.html"},
{"article_id": "M.1456041083.A.5DC", "article_title": "Re: [新聞] 浩鼎報憂 乳癌新藥解盲未過關", "author": "kanhun (兜)", "board": "Stock", "content": "http://i.imgur.com/4EnPHfJ.jpg 不覺得再重演一遍嗎 紅K隔天收黑K 之後就一堆人出殯了 生技的夢不要做太久 有賺到就好 你受的了天天看開盤等於收盤嗎??? 勿忘雞亞 ", "date": "Sun Feb 21 15:51:21 2016", "ip": "112.104.15.239", "message_count": {"all": 24, "boo": 2, "count": 12, "neutral": 8, "push": 14}, "messages": [{"push_content": "有過漲停也是天天開盤幾乎等於收盤阿", "push_ipdatetime": "02/21 15:53", "push_tag": "推", "push_userid": "sad010"}, {"push_content": "只是時間短很多很多", "push_ipdatetime": "02/21 15:53", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "基亞週五盤後開盤，週一就跌停了", "push_ipdatetime": "02/21 15:54", "push_tag": "噓", "push_userid": "markban"}, {"push_content": "推 長得太像了", "push_ipdatetime": "02/21 15:59", "push_tag": "推", "push_userid": "dahlia7357"}, {"push_content": "有圖有推，等開盤", "push_ipdatetime": "02/21 16:00", "push_tag": "推", "push_userid": "qtzero"}, {"push_content": "這次會崩幾根？上次G亞400多崩到100才停", "push_ipdatetime": "02/21 16:02", "push_tag": "噓", "push_userid": "Bv999"}, {"push_content": "剛去看樂透，一價跌停15555票...", "push_ipdatetime": "02/21 16:03", "push_tag": "推", "push_userid": "drt0422"}, {"push_content": "勿忘12根龜苓膏。", "push_ipdatetime": "02/21 16:03", "push_tag": "→", "push_userid": "abbei"}, {"push_content": "我壓那時才3張 我還下了100張", "push_ipdatetime": "02/21 16:06", "push_tag": "推", "push_userid": "std410301"}, {"push_content": "一下就狂飆了", "push_ipdatetime": "02/21 16:07", "push_tag": "→", "push_userid": "std410301"}, {"push_content": "為什麼不早2天po就世", "push_ipdatetime": "02/21 16:11", "push_tag": "推", "push_userid": "TouSan"}, {"push_content": "浩鼎倒公司資金技術也會轉壓中裕，塞翁失馬焉知非", "push_ipdatetime": "02/21 16:14", "push_tag": "推", "push_userid": "sun613"}, {"push_content": "福！", "push_ipdatetime": "02/21 16:14", "push_tag": "→", "push_userid": "sun613"}, {"push_content": "437.5摔到113，19根，從681摔的話 [email protected] @..", "push_ipdatetime": "02/21 16:15", "push_tag": "推", "push_userid": "drt0422"}, {"push_content": "笑死 古板全部說會崩 就是不會崩吧", "push_ipdatetime": "02/21 16:18", "push_tag": "推", "push_userid": "KadourZiani"}, {"push_content": "不會崩", "push_ipdatetime": "02/21 16:19", "push_tag": "推", "push_userid": "u770114"}, {"push_content": "拜託跌到150我才有錢買", "push_ipdatetime": "02/21 16:20", "push_tag": "推", "push_userid": "evil7589"}, {"push_content": "只是把古典機率 改成貝氏機率 去檢定", "push_ipdatetime": "02/21 17:10", "push_tag": "推", "push_userid": "genius721105"}, {"push_content": "挑病人 就可以賣了", "push_ipdatetime": "02/21 17:11", "push_tag": "→", "push_userid": "genius721105"}, {"push_content": "那時跌停7% 現在10% 所以會快一點", "push_ipdatetime": "02/21 18:18", "push_tag": "→", "push_userid": "False"}, {"push_content": "19跟跌停耶 挖賽 有沒有創台股最高紀錄@@", "push_ipdatetime": "02/21 19:29", "push_tag": "推", "push_userid": "wildwoof"}, {"push_content": "浩呆不一樣", "push_ipdatetime": "02/21 20:37", "push_tag": "推", "push_userid": "quif"}, {"push_content": "一定跌停鎖死的", "push_ipdatetime": "02/21 21:22", "push_tag": "→", "push_userid": "bonaqabo"}, {"push_content": "現在進行式", "push_ipdatetime": "02/22 12:11", "push_tag": "→", "push_userid": "kanhun"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456041083.A.5DC.html"},
{"article_id": "M.1456042058.A.5C5", "article_title": "[新聞] 浩鼎於105/02/21召開重大訊息說明記者會", "author": "specialhtm (....)", "board": "Stock", "content": "https://goo.gl/ 縮網址，連結能不能點擊者板規41處份。 3.心得/評論請盡量充實，心得過短將會以44一行文規範水桶處份。 4.請依格式輸入內容，未依格式者板規41砍文處份。 按ctrly可刪除以上內容。 1.原文連結(必須檢附)： https://goo.gl/i4N7Jz 2.原文內容： 日期：2016年02月21日 公司名稱：浩鼎(4174) 主旨：浩鼎於105/02/21召開重大訊息說明記者會 發言人：黃秀美 說明： 1.事實發生日:105/02/21 2.公司名稱:台灣浩鼎生技股份有限公司 3.與公司關係[請輸入本公司或子公司]:本公司 4.相互持股比例:不適用 5.傳播媒體名稱:不適用 6.報導內容:不適用 7.發生緣由: 本公司105/02/21於證券櫃檯買賣中心召開記者會，相關訊息如下： 台灣浩鼎生技股份有限公司（4174）今天宣布，該公司研發的乳癌治療性 疫苗新藥OBI822，以第四期轉移性乳癌病人為對象的第二/三期雙盲臨床試驗， 解盲初步數據顯示，用藥組與對照組相比，主要療效指標(primary endpoint) 未呈現統計學上顯著意義，但其中許多有意義的科學及臨床資訊，已為未來產品 發展提供了明確的方向。 台灣浩鼎生技董事長張念慈強調，這次試驗結果揭曉，浩鼎從中獲得許多有價值 的科學及臨床資訊，參與試驗的病人若產生IgG、IgM免疫抗體反應，在無惡化存活期 PFS(progression free survival) 都可看出非常顯著的改善，總體存活率(OS)方面 也呈現明顯的正面趨勢。這些訊息對於未來全球三期臨床試驗設計，有無比重要的 意義和價值。 台灣浩鼎總經理黃秀美指出，這項試驗明顯指出疫苗激發抗體能力的重要性， 並證實了OBI822產生抗體的能力，而且對能產生有效抗體的族群，證實具有 非常顯著之臨床意義。 台大醫學院外科教授、也是OBI822 多國多中心臨床試驗計畫總主持人黃俊升認為， OBI822乳癌疫苗不同於以往的所有癌症治療，因此此一試驗乃在有限的樣本數下， 試圖找出乳癌疫苗可能有效的族群。初步結果顯示，OBI822能讓產生免疫反應的 患者獲得非常顯著的益處，研究團隊非常振奮，將進一步分析這些數據，希望 更明確地選擇治療族群，在未來研究確認OBI822的治療效益。 美國加州大學舊金山分校海倫迪勒家庭綜合癌症中心乳癌臨床試驗教育主任 教授、H. Rugo醫學博士認為，這項研究顯示，對有免疫反應表現者已達到 主要療效指標，同時證實以免疫療法治療乳腺癌患者的有效性；這些結果和 數據將支持將開展的下一步全球性三期臨床試驗研究，其結果也可進一步闡明 OBI822價值，作為此一充滿希望的新產品註冊基礎。 黃秀美強調，公司會根據這次解盲結果的發現，積極展開下階段的佈局及策略， 除了將按原訂計畫與美國食品藥物管理署(FDA)、歐洲藥物管理局（EMA） 就全球第三期臨床試驗計畫協商外，也將和台灣食藥署(TFDA)展開諮商會議， 並申請前往國際知名醫學會及重要醫學期刊論文發表。為恪遵學術界規範， 浩鼎強調這次解盲完整數據將在國際學術會議上公開發表。 8.因應措施:本公司105/02/21 14:00於證券櫃檯買賣中心召開記者會， 9.其他應敘明事項:新藥開發時程長、投入經費高且並未保證能一定成功， 此等可能使投資面臨風險，投資人應審慎判斷謹慎投資。 3.心得/評論(必需填寫)： 繼續前往ASCO？ 如果有篩選樣本的話，應該會非常成功才是。 所以也不見得是完全的失敗？ ", "date": "Sun Feb 21 16:07:35 2016", "ip": "59.105.177.72", "message_count": {"all": 53, "boo": 2, "count": 15, "neutral": 34, "push": 17}, "messages": [{"push_content": "就是失敗阿 你回頭看看當初的基亞 也是講差不多的話", "push_ipdatetime": "02/21 16:10", "push_tag": "推", "push_userid": "doudoulon"}, {"push_content": "感覺自我安慰的成分很重", "push_ipdatetime": "02/21 16:10", "push_tag": "推", "push_userid": "sad010"}, {"push_content": "二期臨床才多少實驗數據", "push_ipdatetime": "02/21 16:10", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "就可以看出來樣本的差異...", "push_ipdatetime": "02/21 16:11", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "說不定個體樣本只有一個人而已", "push_ipdatetime": "02/21 16:11", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "解讀就是統計上=>不顯著 其他=>有很顯著的\"意義\"", "push_ipdatetime": "02/21 16:11", "push_tag": "→", "push_userid": "doudoulon"}, {"push_content": "因為總實驗人數只有不到百人", "push_ipdatetime": "02/21 16:11", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "所以比例很高就\"顯著\"了是吧?", "push_ipdatetime": "02/21 16:11", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "崩盤的可能性還是9成9", "push_ipdatetime": "02/21 16:12", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "總人數不是300多人嗎", "push_ipdatetime": "02/21 16:12", "push_tag": "推", "push_userid": "yangpuhols"}, {"push_content": "浩鼎本業是炒股", "push_ipdatetime": "02/21 16:13", "push_tag": "噓", "push_userid": "Daikin"}, {"push_content": "直持他600股價的可不是這種似是而非的消息", "push_ipdatetime": "02/21 16:14", "push_tag": "推", "push_userid": "dahlia7357"}, {"push_content": "支持股價的絕對是統計學上的顯著療效 而不是安慰", "push_ipdatetime": "02/21 16:14", "push_tag": "→", "push_userid": "dahlia7357"}, {"push_content": "公司的技術資金錢改壓中裕！", "push_ipdatetime": "02/21 16:15", "push_tag": "推", "push_userid": "sun613"}, {"push_content": "重點在投資人的心理層面，怎麼說應該都是沒用的..", "push_ipdatetime": "02/21 16:17", "push_tag": "→", "push_userid": "drt0422"}, {"push_content": "是要拼逆轉勝嗎？", "push_ipdatetime": "02/21 16:17", "push_tag": "→", "push_userid": "hun410705"}, {"push_content": "要問問浩鼎漲到今天 支持的消息是哪一種", "push_ipdatetime": "02/21 16:18", "push_tag": "推", "push_userid": "EasternAsh"}, {"push_content": "是過解盲? 還是沒過然後再搞個半年一年?", "push_ipdatetime": "02/21 16:19", "push_tag": "→", "push_userid": "EasternAsh"}, {"push_content": "試驗人數越少，兩組的差異必須要非常明顯才算有意義", "push_ipdatetime": "02/21 16:19", "push_tag": "推", "push_userid": "gingsow"}, {"push_content": "支持浩鼎到今天的當然是薛丁格的貓", "push_ipdatetime": "02/21 16:20", "push_tag": "推", "push_userid": "dahlia7357"}, {"push_content": "不然浩鼎的無副作用 免疫療法等等 是已知且樂觀的", "push_ipdatetime": "02/21 16:20", "push_tag": "→", "push_userid": "EasternAsh"}, {"push_content": "我沒記錯這個試驗只有300多人參加", "push_ipdatetime": "02/21 16:20", "push_tag": "→", "push_userid": "gingsow"}, {"push_content": "一般癌症三期臨床試驗都要500人以上", "push_ipdatetime": "02/21 16:21", "push_tag": "→", "push_userid": "gingsow"}, {"push_content": "不可能拿三百元的支撐點 去解釋支撐在七百的理由", "push_ipdatetime": "02/21 16:21", "push_tag": "→", "push_userid": "EasternAsh"}, {"push_content": "基亞第二", "push_ipdatetime": "02/21 16:23", "push_tag": "→", "push_userid": "Boyzone"}, {"push_content": "當初基亞也說要繼續試，傻傻相信的人還抱著呢！我鄰", "push_ipdatetime": "02/21 16:31", "push_tag": "推", "push_userid": "predraq"}, {"push_content": "居就有....唉 真的又是一場悲劇", "push_ipdatetime": "02/21 16:31", "push_tag": "→", "push_userid": "predraq"}, {"push_content": "笑死人 根本炒股炒上癮 primary endpoint fail還不", "push_ipdatetime": "02/21 16:32", "push_tag": "推", "push_userid": "isoniazid"}, {"push_content": "敢講明", "push_ipdatetime": "02/21 16:32", "push_tag": "→", "push_userid": "isoniazid"}, {"push_content": "不過還抱著基亞的鄰居還比我好，我解盲前一天價值三", "push_ipdatetime": "02/21 16:33", "push_tag": "→", "push_userid": "predraq"}, {"push_content": "千萬基亞認購權證吃龜苓膏，我永遠記得那一天 七月", "push_ipdatetime": "02/21 16:33", "push_tag": "→", "push_userid": "predraq"}, {"push_content": "二十八號.....", "push_ipdatetime": "02/21 16:33", "push_tag": "→", "push_userid": "predraq"}, {"push_content": "3000萬拚權證..真有種..", "push_ipdatetime": "02/21 16:42", "push_tag": "→", "push_userid": "cloud701002"}, {"push_content": "三千萬??", "push_ipdatetime": "02/21 16:42", "push_tag": "推", "push_userid": "runislife"}, {"push_content": "投入八百萬，玩到前一天市值三千，我還記得算了很久", "push_ipdatetime": "02/21 16:52", "push_tag": "推", "push_userid": "predraq"}, {"push_content": "覺得p值必過無疑，還有海外原來技轉的公司也大漲，", "push_ipdatetime": "02/21 16:52", "push_tag": "→", "push_userid": "predraq"}, {"push_content": "甚至傳出要併購，種種消息使得財迷心竅...所以不要", "push_ipdatetime": "02/21 16:52", "push_tag": "→", "push_userid": "predraq"}, {"push_content": "再問為何不想出了，莫再提.....只是看到如今歷史重", "push_ipdatetime": "02/21 16:52", "push_tag": "→", "push_userid": "predraq"}, {"push_content": "演才有感而發", "push_ipdatetime": "02/21 16:52", "push_tag": "→", "push_userid": "predraq"}, {"push_content": "解盲失敗但是不是完全沒收穫 只是不知道這些收穫何", "push_ipdatetime": "02/21 16:52", "push_tag": "噓", "push_userid": "FiveLine"}, {"push_content": "用", "push_ipdatetime": "02/21 16:52", "push_tag": "→", "push_userid": "FiveLine"}, {"push_content": "何時有用", "push_ipdatetime": "02/21 16:53", "push_tag": "→", "push_userid": "FiveLine"}, {"push_content": "已空其他生技股 來個全面跌停吧!!!!!!!!!!!!", "push_ipdatetime": "02/21 17:03", "push_tag": "推", "push_userid": "aquahau"}, {"push_content": "已空+1", "push_ipdatetime": "02/21 17:12", "push_tag": "推", "push_userid": "blacknotes"}, {"push_content": "３０００萬權證！？ 我浩鼎才１０００欸，上禮拜都", "push_ipdatetime": "02/21 17:50", "push_tag": "推", "push_userid": "zx2751206"}, {"push_content": "出光了呵呵！ 爽", "push_ipdatetime": "02/21 17:50", "push_tag": "→", "push_userid": "zx2751206"}, {"push_content": "永遠都是要比別人還貪  可是恐懼的時候要更恐懼提早", "push_ipdatetime": "02/21 18:00", "push_tag": "推", "push_userid": "exrickey"}, {"push_content": "呵呵  掰掰", "push_ipdatetime": "02/21 18:02", "push_tag": "推", "push_userid": "MorrisChang"}, {"push_content": "四海遊龍啦...", "push_ipdatetime": "02/21 19:27", "push_tag": "→", "push_userid": "cocount"}, {"push_content": "浩鼎會不會申請暫停交易好幾個營業日XDD", "push_ipdatetime": "02/21 19:30", "push_tag": "→", "push_userid": "wildwoof"}, {"push_content": "不敢公布真實實驗數字只敢用文字唬弄人阿 存活率有", "push_ipdatetime": "02/21 19:31", "push_tag": "→", "push_userid": "wildwoof"}, {"push_content": "沒有比目前市面上的用藥高5% = =", "push_ipdatetime": "02/21 19:31", "push_tag": "→", "push_userid": "wildwoof"}, {"push_content": "好險持股是原料", "push_ipdatetime": "02/21 21:24", "push_tag": "→", "push_userid": "matt111501"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456042058.A.5C5.html"},
{"article_id": "M.1456042852.A.A22", "article_title": "Re: [新聞] 浩鼎將變更設計 擴大三期臨床試驗", "author": "blty (我知道‧你不知道)", "board": "Stock", "content": "小弟我潛水很久，接觸股票並沒有很多年 但看到版上很多前輩的評論，實在覺得很多人根本沒做功課 首先，我並沒有浩鼎的股票，因為太貴買不起QQ 但我蠻看好他的，所以略有研究。 對於這次解盲結果，我覺得不算失敗，但也沒成功(明天看股價反應就知道了)。 看了很多篇回文，有人問為什麼都沒數據 因為浩鼎本來就沒打算今天公布數據，數據要拿去六月美國腫瘤學會的研討會發表 根據報導p值不夠(沒顯著統計意義)，但又有改善bal bal~ 應該是要說明，浩鼎這次的臨床並無篩選病患。 有做功課的前輩應該會知道浩鼎的藥物作用機制，那麼有無篩選病患， 就跟臨床的成敗有很大的關係了。 所以才會產生沒意義但有效果，接下來應該是要針對有表現抗原的病患去做收案， 這樣一來效果或許就會有統計意義了。 但說了那麼多，我覺得看壞的依舊還是看壞XDD ", "date": "Sun Feb 21 16:20:49 2016", "ip": "115.43.126.53", "message_count": {"all": 61, "boo": 5, "count": 12, "neutral": 39, "push": 17}, "messages": [{"push_content": "測試有問題 所以才沒有過", "push_ipdatetime": "02/21 16:24", "push_tag": "推", "push_userid": "g10"}, {"push_content": "裁判不公", "push_ipdatetime": "02/21 16:26", "push_tag": "→", "push_userid": "Boyzone"}, {"push_content": "這跟裁判沒有關係吧XDD 就報導的結果來看", "push_ipdatetime": "02/21 16:27", "push_tag": "→", "push_userid": "blty"}, {"push_content": "就是當初設計太有自信沒去篩選合適病患而已", "push_ipdatetime": "02/21 16:28", "push_tag": "→", "push_userid": "blty"}, {"push_content": "好藥不用篩選病患", "push_ipdatetime": "02/21 16:30", "push_tag": "噓", "push_userid": "AlexLeee"}, {"push_content": "A大你以為世界上萬能藥?", "push_ipdatetime": "02/21 16:31", "push_tag": "→", "push_userid": "blty"}, {"push_content": "現行的標靶藥物都不一定對每位都病患有用了", "push_ipdatetime": "02/21 16:32", "push_tag": "→", "push_userid": "blty"}, {"push_content": "沒篩選病患族群?當計畫主持人是上世紀穿越來的嗎？", "push_ipdatetime": "02/21 16:35", "push_tag": "推", "push_userid": "darksaber"}, {"push_content": "根據之前浩鼎說法是沒篩選阿", "push_ipdatetime": "02/21 16:36", "push_tag": "→", "push_userid": "blty"}, {"push_content": "看起來是死在沒篩選", "push_ipdatetime": "02/21 16:37", "push_tag": "推", "push_userid": "laject"}, {"push_content": "但是這也表示出該藥物並非對每個人有用", "push_ipdatetime": "02/21 16:38", "push_tag": "→", "push_userid": "laject"}, {"push_content": "下個突破點就是這吧", "push_ipdatetime": "02/21 16:39", "push_tag": "→", "push_userid": "laject"}, {"push_content": "現用藥物 賀癌平  適應率 也只有 25%", "push_ipdatetime": "02/21 16:39", "push_tag": "推", "push_userid": "iptv"}, {"push_content": "藥物並非針對每個人都有效", "push_ipdatetime": "02/21 16:41", "push_tag": "→", "push_userid": "laject"}, {"push_content": "這點才是需要被理解的", "push_ipdatetime": "02/21 16:42", "push_tag": "→", "push_userid": "laject"}, {"push_content": "一堆人講的話 我快笑死 作用機制都沒了解rrrr", "push_ipdatetime": "02/21 16:42", "push_tag": "推", "push_userid": "sinple"}, {"push_content": "沒錯，就是這樣!", "push_ipdatetime": "02/21 16:43", "push_tag": "→", "push_userid": "blty"}, {"push_content": "-- 完全看不出你有研究在哪阿", "push_ipdatetime": "02/21 16:56", "push_tag": "噓", "push_userid": "IAmAwesome"}, {"push_content": "要了解100%病患適用的商業價值不等於20%病患適用的", "push_ipdatetime": "02/21 16:59", "push_tag": "→", "push_userid": "cafewang"}, {"push_content": "篩選次群都會影響未來的市場預估", "push_ipdatetime": "02/21 16:59", "push_tag": "→", "push_userid": "cafewang"}, {"push_content": "如果硬要新藥成功，可以從中挑選出極少數有效的人", "push_ipdatetime": "02/21 17:00", "push_tag": "→", "push_userid": "cafewang"}, {"push_content": "那就算通過了，上市銷售的成本會入不敷出", "push_ipdatetime": "02/21 17:01", "push_tag": "→", "push_userid": "cafewang"}, {"push_content": "I大我文中想說的概念是要做功課", "push_ipdatetime": "02/21 17:03", "push_tag": "→", "push_userid": "blty"}, {"push_content": "我下午看了很多回文，不少前輩連需要篩選都不知道", "push_ipdatetime": "02/21 17:05", "push_tag": "→", "push_userid": "blty"}, {"push_content": "c大你講到重點了，所以股價應該會修正", "push_ipdatetime": "02/21 17:06", "push_tag": "→", "push_userid": "blty"}, {"push_content": "即便通過也不會噴到太高", "push_ipdatetime": "02/21 17:06", "push_tag": "→", "push_userid": "blty"}, {"push_content": "傻子 不拉高怎麼有肉", "push_ipdatetime": "02/21 17:09", "push_tag": "推", "push_userid": "smad"}, {"push_content": "總而言之講這多就是目前沒這個價值 準備迎接崩回起", "push_ipdatetime": "02/21 18:01", "push_tag": "→", "push_userid": "exrickey"}, {"push_content": "漲點  歡樂一百點拉~~~~耶", "push_ipdatetime": "02/21 18:02", "push_tag": "→", "push_userid": "exrickey"}, {"push_content": "不過有長知識給推~~~", "push_ipdatetime": "02/21 18:09", "push_tag": "推", "push_userid": "exrickey"}, {"push_content": "就算有成功，以後上市也只會給有反應的人用藥", "push_ipdatetime": "02/21 18:32", "push_tag": "推", "push_userid": "Rudy"}, {"push_content": "年銷售預估值，本來就有打折過了，這部分應該沒差", "push_ipdatetime": "02/21 18:33", "push_tag": "→", "push_userid": "Rudy"}, {"push_content": "只是還要再做Phase 3，聽張董說法，", "push_ipdatetime": "02/21 18:35", "push_tag": "推", "push_userid": "Rudy"}, {"push_content": "規模會比現在這個Phase 2/3還要大，燒錢啊......", "push_ipdatetime": "02/21 18:36", "push_tag": "→", "push_userid": "Rudy"}, {"push_content": "還有就是，今年能拿到一張肥約的機會，大概也沒有了", "push_ipdatetime": "02/21 18:37", "push_tag": "→", "push_userid": "Rudy"}, {"push_content": "http://udn.com/news/story/6/1515413", "push_ipdatetime": "02/21 18:48", "push_tag": "推", "push_userid": "d147258"}, {"push_content": "股價700佈算失敗~", "push_ipdatetime": "02/21 18:54", "push_tag": "噓", "push_userid": "f204137"}, {"push_content": "問題是篩選過的結果會如何只有天知道", "push_ipdatetime": "02/21 18:55", "push_tag": "推", "push_userid": "samwu995"}, {"push_content": "現在的股價應該是預期會有好消息", "push_ipdatetime": "02/21 18:56", "push_tag": "→", "push_userid": "samwu995"}, {"push_content": "Clinical trial 確實本就有inclusive 跟exclusive c", "push_ipdatetime": "02/21 19:11", "push_tag": "推", "push_userid": "allen999988"}, {"push_content": "riteria  看試驗案想怎麼篩", "push_ipdatetime": "02/21 19:11", "push_tag": "→", "push_userid": "allen999988"}, {"push_content": "哪裡有作用機制 好歹我修過生化可以看 下", "push_ipdatetime": "02/21 19:33", "push_tag": "推", "push_userid": "The5F"}, {"push_content": "好藥不用篩選XDDDDDD 本日最好笑", "push_ipdatetime": "02/21 19:55", "push_tag": "噓", "push_userid": "mocha200e"}, {"push_content": "抗原抗體傻傻分不清", "push_ipdatetime": "02/21 20:09", "push_tag": "噓", "push_userid": "elijah2012"}, {"push_content": "我沒記錯的話他是針對癌症細胞上表現出的抗原", "push_ipdatetime": "02/21 20:35", "push_tag": "→", "push_userid": "blty"}, {"push_content": "去做設計的，所以我說篩選抗原'", "push_ipdatetime": "02/21 20:35", "push_tag": "→", "push_userid": "blty"}, {"push_content": "我更正一下看法，也有可能是有Global-H的人", "push_ipdatetime": "02/21 21:48", "push_tag": "推", "push_userid": "Rudy"}, {"push_content": "成功產生抗體的比例不夠高，那這市場就縮小了", "push_ipdatetime": "02/21 21:48", "push_tag": "→", "push_userid": "Rudy"}, {"push_content": "因為張董是強調有抗體的人，表現都很好", "push_ipdatetime": "02/21 21:49", "push_tag": "→", "push_userid": "Rudy"}, {"push_content": "所以才要強調統計數據阿....", "push_ipdatetime": "02/21 22:15", "push_tag": "推", "push_userid": "woods0598"}, {"push_content": "所以下次的臨床 就是用那些打了有抗體的才實驗?", "push_ipdatetime": "02/21 22:41", "push_tag": "推", "push_userid": "sad010"}, {"push_content": "先射箭再畫靶的概念?", "push_ipdatetime": "02/21 22:42", "push_tag": "→", "push_userid": "sad010"}, {"push_content": "先畫靶在射箭還是先射箭再畫靶?", "push_ipdatetime": "02/21 22:49", "push_tag": "→", "push_userid": "blty"}, {"push_content": "個人認為，如果先篩選出有抗原的患者在進行臨床", "push_ipdatetime": "02/21 22:53", "push_tag": "→", "push_userid": "blty"}, {"push_content": "結果可能會有意義", "push_ipdatetime": "02/21 22:54", "push_tag": "→", "push_userid": "blty"}, {"push_content": "我所說的抗原是癌細胞上的", "push_ipdatetime": "02/21 22:55", "push_tag": "→", "push_userid": "blty"}, {"push_content": "樓上他們應該已經這麼做了..現在要增加的是", "push_ipdatetime": "02/21 23:47", "push_tag": "推", "push_userid": "rasaze"}, {"push_content": "如何分辨打進去有無法免疫反應產生", "push_ipdatetime": "02/21 23:47", "push_tag": "→", "push_userid": "rasaze"}, {"push_content": "我映像中當初浩鼎的設計是沒篩抗原耶..", "push_ipdatetime": "02/21 23:50", "push_tag": "→", "push_userid": "blty"}, {"push_content": "為什麼新錄取員工平均素質這麼差? 爛人資:忘了篩選", "push_ipdatetime": "02/22 00:19", "push_tag": "→", "push_userid": "SweetLee"}, {"push_content": "為什麼實驗結果這麼差? 爛主持人: 我忘了篩選", "push_ipdatetime": "02/22 00:19", "push_tag": "→", "push_userid": "SweetLee"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456042852.A.A22.html"},
{"article_id": "M.1456042892.A.1F6", "article_title": "Re: [新聞] 浩鼎乳癌新藥解盲　有利免疫抗體生成", "author": "sayhello (志氣!)", "board": "Stock", "content": "客觀的分析一下 1.目前的數據來看試驗是不顯著的(沒過關)，但是對於少數部分病人有效果， 公司派對於這點是樂觀的，所以皆下來就是去美國、歐盟重新做一個大型三期 並且把實驗設計改成OBI822打進去有免疫反應的人才納入實驗中 在更精確的收病人上，接下來容易做出來一份好的臨床實驗 (但是有沒有辦法挑出來這些病人呢? 開發晶片? 試劑? 還是只能打針觀察) 但是時間呢? 需要大概3年才會有下一次翻牌了 如果用NPV的角度來看這個事情，那就是看時間遞延多久， 台灣東南亞的收入可能遞延3年左右，但全球市場來看 亞洲市場其實很小 應該可以說是占浩鼎的價值510%，亞洲市場其實不重要。 真的要大賺應該還是要歐美市場，那邊藥價才高 所以下一步怎麼走，去歐美怎樣設計臨床實驗才是最重要的 短線上就是失望的籌碼砍出來，短線近來賭的人認賠殺出 有的媒體可以利多解讀 文筆真的不錯 2.現在的重點是浩鼎沒有公布的地方 重點是那些有抗體反應的人，到底效果是怎麼樣 可能有的病人超好，有的效果普普，如果以後實驗設計往這個方向去修改， 那他們在ASCO、ESMO發表的細部的數據，這邊就是要觀察的 但有抗體反應的人有效果 不等於藥就一定會過關喔 因為你還是要跟現有的藥物做比較，免疫療法一堆大廠都在玩 MERCK、BMS等等，人家可是走在前面，雖然浩鼎是一個新的機轉， 但是台灣這次沒過關，已經讓大家原本預期的申請突破性療法 免做少做三期臨床的願望落空，還是要按照計畫一步步來 如果今年開始申請歐美3期IND 2年收案 1年看數據 1年申請藥證 最快也是20182019年 藥物上市，在這個數據的空窗之間，其實是很久的 台灣的下一步，就是看跟TFDA溝通的怎樣，如果背後有一些大咖介入， 說不定就能縮小適應症的模式申請藥證了 也是有可能。 反正名嘴護航一下，應該就OK了 3.股價方面，以NPV的角度，亞洲市場遞延，影響部分地區現金流往後 台灣這次沒過關，將造成市場信心下滑、要求的折現率提高 以及修改實驗設計，將會造成病患的減少，造成潛在的銷售額下降 粗估短線上評價少個20%是合理的， 但是不能說浩鼎就跟基亞一樣無量一直往下跌停 因為玩的東西跟背後的TEAM完全不同等級 生技產業一個臨床動輒23年，其實是需要長線的資金來投資的 禮拜一開盤如果開始大回檔，那其實跌下來是製造了長線買點 給願意賭、願意等的人進來投資 短線上當然是先撤退再說，好在沒幾家投信有浩鼎。 到一月為止只有統一、永豐跟野村有。 ", "date": "Sun Feb 21 16:21:28 2016", "ip": "118.160.235.122", "message_count": {"all": 37, "boo": 1, "count": 19, "neutral": 16, "push": 20}, "messages": [{"push_content": "推", "push_ipdatetime": "02/21 16:22", "push_tag": "推", "push_userid": "gingsow"}, {"push_content": "你是在這個產業的對吧", "push_ipdatetime": "02/21 16:23", "push_tag": "→", "push_userid": "gingsow"}, {"push_content": "基亞第二", "push_ipdatetime": "02/21 16:23", "push_tag": "推", "push_userid": "Boyzone"}, {"push_content": "20%恐怕太樂觀", "push_ipdatetime": "02/21 16:23", "push_tag": "→", "push_userid": "abuu0929"}, {"push_content": "長線願意賭翻倍機會的話 其實有更多股票有跡可循", "push_ipdatetime": "02/21 16:25", "push_tag": "推", "push_userid": "EasternAsh"}, {"push_content": "要玩生技 第一無非是要快狠準 還有是翻倍在翻倍", "push_ipdatetime": "02/21 16:25", "push_tag": "→", "push_userid": "EasternAsh"}, {"push_content": "先看300再找買點吧 下個結果出來至少要3年後", "push_ipdatetime": "02/21 16:26", "push_tag": "推", "push_userid": "Boyzone"}, {"push_content": "這才符合投資生技的不確定性和風險", "push_ipdatetime": "02/21 16:27", "push_tag": "→", "push_userid": "EasternAsh"}, {"push_content": "3年後  當然先把資金抽出來啊...", "push_ipdatetime": "02/21 16:35", "push_tag": "推", "push_userid": "ZakuSIN"}, {"push_content": "3年後，再賭 不用現在賭", "push_ipdatetime": "02/21 16:37", "push_tag": "推", "push_userid": "g10"}, {"push_content": "照美股一天先跌個75%再談之後，可惜台股一天只能10%", "push_ipdatetime": "02/21 16:43", "push_tag": "→", "push_userid": "pili980"}, {"push_content": "推這篇，一堆人亂解釋解盲沒過和效果顯助的意思，", "push_ipdatetime": "02/21 16:49", "push_tag": "推", "push_userid": "bravejared"}, {"push_content": "看了直搖頭", "push_ipdatetime": "02/21 16:49", "push_tag": "→", "push_userid": "bravejared"}, {"push_content": "野村星期五還買了不少..哪來的信心@@", "push_ipdatetime": "02/21 16:58", "push_tag": "推", "push_userid": "siarim"}, {"push_content": "結果現在要挑特定病人 搞不好病人族群比herceptin", "push_ipdatetime": "02/21 17:04", "push_tag": "→", "push_userid": "nickdarren"}, {"push_content": "小上不少", "push_ipdatetime": "02/21 17:05", "push_tag": "→", "push_userid": "nickdarren"}, {"push_content": "3176算是製造了長線買點？？", "push_ipdatetime": "02/21 17:06", "push_tag": "推", "push_userid": "DarkBuster"}, {"push_content": "我比較想只知道副作用的資料", "push_ipdatetime": "02/21 17:15", "push_tag": "推", "push_userid": "cafewang"}, {"push_content": "新機轉的最大變數就是可能的副作用，影響力更大", "push_ipdatetime": "02/21 17:16", "push_tag": "→", "push_userid": "cafewang"}, {"push_content": "大家都把申請藥證想得太美好了!!FDA沒過TFDA會給過?", "push_ipdatetime": "02/21 17:27", "push_tag": "→", "push_userid": "mokinased"}, {"push_content": "原po應該也是在藥廠？ 賣學名藥嗎？", "push_ipdatetime": "02/21 17:34", "push_tag": "推", "push_userid": "teardropbox"}, {"push_content": "難講哦...如果有特殊的助力的話...", "push_ipdatetime": "02/21 17:34", "push_tag": "推", "push_userid": "gingsow"}, {"push_content": "生技股是用來翻倍再翻倍的 不是用來等3年的........", "push_ipdatetime": "02/21 17:45", "push_tag": "噓", "push_userid": "tangolosss"}, {"push_content": "你要3年翻倍?? 3年我可以找給你10支以上翻倍股票 XD", "push_ipdatetime": "02/21 17:46", "push_tag": "→", "push_userid": "tangolosss"}, {"push_content": "第2點其實就已經破了當初的期待 從保送生降到去學測", "push_ipdatetime": "02/21 17:46", "push_tag": "推", "push_userid": "future2010"}, {"push_content": "sayhello大，以822的安全性，您可能忽略了聯合用藥", "push_ipdatetime": "02/21 18:02", "push_tag": "推", "push_userid": "keanu2110"}, {"push_content": "的潛力，只不過授權價碼應該會被砍下去", "push_ipdatetime": "02/21 18:03", "push_tag": "→", "push_userid": "keanu2110"}, {"push_content": "嗯啊 不過真的會投資的人一定是現在全部撤出XDDDDD", "push_ipdatetime": "02/21 18:07", "push_tag": "推", "push_userid": "exrickey"}, {"push_content": "你說的跟我想的一樣。看有沒有詳細數據揭露。如果可", "push_ipdatetime": "02/21 18:41", "push_tag": "推", "push_userid": "jrkb1986"}, {"push_content": "以去asco 那代表還是有機會。只是收割又要等很久", "push_ipdatetime": "02/21 18:41", "push_tag": "→", "push_userid": "jrkb1986"}, {"push_content": "恭喜套三年", "push_ipdatetime": "02/21 19:20", "push_tag": "推", "push_userid": "monarch0301"}, {"push_content": "理性分析是不會跌很慘 但是有多少買浩鼎的是專業人", "push_ipdatetime": "02/21 19:37", "push_tag": "→", "push_userid": "wildwoof"}, {"push_content": "士 可以抱著一個期待繼續等= =?", "push_ipdatetime": "02/21 19:38", "push_tag": "→", "push_userid": "wildwoof"}, {"push_content": "專業的比散戶更不會去賭", "push_ipdatetime": "02/21 19:53", "push_tag": "推", "push_userid": "rjie"}, {"push_content": "好文", "push_ipdatetime": "02/21 20:54", "push_tag": "推", "push_userid": "AdamHuangNew"}, {"push_content": "不論公佈不公佈效果 大部分人還是會心生懷疑", "push_ipdatetime": "02/21 22:23", "push_tag": "推", "push_userid": "woods0598"}, {"push_content": "就算公佈了大部分人也看不懂 所以就不公佈吧", "push_ipdatetime": "02/21 22:24", "push_tag": "→", "push_userid": "woods0598"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456042892.A.1F6.html"},
{"article_id": "M.1456043290.A.337", "article_title": "Re: [新聞] 浩鼎將變更設計 擴大三期臨床試驗", "author": "Rudy (荒野遊俠)", "board": "Stock", "content": "解盲結果出來，有新聞說失敗，有新聞說成功，這也蠻有趣的。 其實就一件事，統計上的 P Value不夠好，所以失敗。 那成功的說法哪來的？ 這就要牽扯到，Global H 在一般乳癌患者有反應的約佔 80%， 對於剩下20%沒反應的，浩鼎的藥本來就一點用也沒有。 然後公司決定，既然有80%，那這次臨床就不篩選患者了。 再然後很不幸的，實驗組有 Global H反應的不夠多。 成功派的說法是，有產生抗體反應的人，藥效很好，比對照組好很多， 統計P Value 也一定夠好。 所以張董有說，在台灣還是會去申請藥證， 但是需要去溝通，看能不能改用篩選後的病人當結果。 恩恩，不過台灣不是重點，重點是美國後續的動作。 之前浩鼎有說，解盲的四種結果。 1.數據超好，直接申請藥證 2.數據不錯，補做小三期臨床 3.正常三期臨床 4.失敗，中止實驗 解盲前一般看法是2機率最高， 這次後續顯然要走3路徑，算是不如預期的結果。 三期臨床燒錢燒時間，以現在股價來講，會有不少修正空間。 但我覺得不會像基亞那麼慘，基亞就真的是失敗， 浩鼎修正一下臨床設計，篩一下病患，還是有戲唱的。 ", "date": "Sun Feb 21 16:28:07 2016", "ip": "1.34.243.167", "message_count": {"all": 66, "boo": 0, "count": 26, "neutral": 40, "push": 26}, "messages": [{"push_content": "癌症還要篩病患，那這顆藥還真廢", "push_ipdatetime": "02/21 16:29", "push_tag": "推", "push_userid": "evil7589"}, {"push_content": "有種就宣布有效果的到底有多少人？", "push_ipdatetime": "02/21 16:31", "push_tag": "推", "push_userid": "shoungson"}, {"push_content": "問一下..台灣真的有成功案例嗎..", "push_ipdatetime": "02/21 16:32", "push_tag": "→", "push_userid": "fubon518"}, {"push_content": "1百個1個有效 就篩選1個當案例嗎", "push_ipdatetime": "02/21 16:32", "push_tag": "→", "push_userid": "scratch01"}, {"push_content": "癌症本來就要篩選病患阿>>>>個人化醫療", "push_ipdatetime": "02/21 16:33", "push_tag": "→", "push_userid": "ilovehebe"}, {"push_content": "說不用篩病患的前輩，科普知識要再加強", "push_ipdatetime": "02/21 16:34", "push_tag": "→", "push_userid": "blty"}, {"push_content": "光人種差異，藥的效果可能就差很多", "push_ipdatetime": "02/21 16:36", "push_tag": "→", "push_userid": "fantasywing"}, {"push_content": "乳癌第一大藥Herceptin,只對23%的病患有效", "push_ipdatetime": "02/21 16:38", "push_tag": "→", "push_userid": "Rudy"}, {"push_content": "當初臨床就有篩選病患，只針對這些人實驗", "push_ipdatetime": "02/21 16:39", "push_tag": "→", "push_userid": "Rudy"}, {"push_content": "然後Herceptin一年賣了6B usd", "push_ipdatetime": "02/21 16:41", "push_tag": "→", "push_userid": "Rudy"}, {"push_content": "實驗設計失敗", "push_ipdatetime": "02/21 16:41", "push_tag": "推", "push_userid": "b0850"}, {"push_content": "大大，我覺得你的解釋有問題耶，如果對global h 抗", "push_ipdatetime": "02/21 16:44", "push_tag": "→", "push_userid": "bravejared"}, {"push_content": "原有反應的人比例那麼高，浩鼎又為何要花錢研究另外", "push_ipdatetime": "02/21 16:44", "push_tag": "→", "push_userid": "bravejared"}, {"push_content": "接上KLH載體的方法來刺激抗體啟動免疫反應？", "push_ipdatetime": "02/21 16:44", "push_tag": "→", "push_userid": "bravejared"}, {"push_content": "推這篇～", "push_ipdatetime": "02/21 16:45", "push_tag": "推", "push_userid": "sinple"}, {"push_content": "1看尹董事長後續動作吧", "push_ipdatetime": "02/21 16:50", "push_tag": "推", "push_userid": "les0818"}, {"push_content": "如果篩選病患，那當初預估的市場銷售值將大幅縮水", "push_ipdatetime": "02/21 16:51", "push_tag": "→", "push_userid": "cafewang"}, {"push_content": "合理市值也會大幅下修", "push_ipdatetime": "02/21 16:51", "push_tag": "→", "push_userid": "cafewang"}, {"push_content": "如果當初直接走孤兒藥，篩選真正有反應的族群，", "push_ipdatetime": "02/21 16:52", "push_tag": "→", "push_userid": "cafewang"}, {"push_content": "尹如果繼續加碼 很快能止跌", "push_ipdatetime": "02/21 16:53", "push_tag": "推", "push_userid": "yilanism"}, {"push_content": "換個角度談，商業潛值都得下調", "push_ipdatetime": "02/21 16:54", "push_tag": "→", "push_userid": "cafewang"}, {"push_content": "賀癌平本身就是針對HER2-neu基因過度表現的族群", "push_ipdatetime": "02/21 16:56", "push_tag": "→", "push_userid": "cafewang"}, {"push_content": "現在這個情況，浩鼎要長期投資了，但目前股價太高", "push_ipdatetime": "02/21 16:56", "push_tag": "推", "push_userid": "d147258"}, {"push_content": "其比例大約是所有乳癌患者的25%", "push_ipdatetime": "02/21 16:57", "push_tag": "→", "push_userid": "cafewang"}, {"push_content": "不是長期投資的價格", "push_ipdatetime": "02/21 16:57", "push_tag": "→", "push_userid": "d147258"}, {"push_content": "不是失敗了，再篩選次群體的", "push_ipdatetime": "02/21 16:57", "push_tag": "→", "push_userid": "cafewang"}, {"push_content": "賀癌平本身就是有針對 但浩鼎這個一開始就沒針對吧", "push_ipdatetime": "02/21 16:58", "push_tag": "推", "push_userid": "EasternAsh"}, {"push_content": "浩鼎當初讓人期待也是這種療法的效果", "push_ipdatetime": "02/21 17:01", "push_tag": "→", "push_userid": "EasternAsh"}, {"push_content": "當除不是就是要吃Herceptin 吃不到的那七成市場", "push_ipdatetime": "02/21 17:04", "push_tag": "推", "push_userid": "nickdarren"}, {"push_content": "很多標靶藥都有篩選族群", "push_ipdatetime": "02/21 17:06", "push_tag": "推", "push_userid": "gingsow"}, {"push_content": "乳癌，肺癌，大腸癌都有", "push_ipdatetime": "02/21 17:06", "push_tag": "→", "push_userid": "gingsow"}, {"push_content": "乳癌目前治療效果算非常好的疾病 表示現有藥物不差", "push_ipdatetime": "02/21 17:08", "push_tag": "推", "push_userid": "nickdarren"}, {"push_content": "新藥要成功除了學理成功，商業價值也要成功才有價", "push_ipdatetime": "02/21 17:08", "push_tag": "→", "push_userid": "cafewang"}, {"push_content": "印象中沒有其他癌症第四期的存活率比乳癌好", "push_ipdatetime": "02/21 17:08", "push_tag": "→", "push_userid": "nickdarren"}, {"push_content": "若挑選有反應的病患群體，NPV誓必下調", "push_ipdatetime": "02/21 17:09", "push_tag": "→", "push_userid": "cafewang"}, {"push_content": "大腸癌存活期也很長", "push_ipdatetime": "02/21 17:10", "push_tag": "推", "push_userid": "gingsow"}, {"push_content": "回應bravejared兄，KLH是這次的實驗，新的是OBI-833", "push_ipdatetime": "02/21 17:11", "push_tag": "→", "push_userid": "Rudy"}, {"push_content": "colon ca stage IV 5 years survive rate11%", "push_ipdatetime": "02/21 17:11", "push_tag": "推", "push_userid": "nickdarren"}, {"push_content": "以球賽比喻，就是拼全力但差ㄧ點進冠軍賽，但球員", "push_ipdatetime": "02/21 17:12", "push_tag": "推", "push_userid": "sun613"}, {"push_content": "表現可圈可點，結論：還是輸！", "push_ipdatetime": "02/21 17:12", "push_tag": "→", "push_userid": "sun613"}, {"push_content": "載體不同改用DT，差別好像是長效抗體IgG會比較多", "push_ipdatetime": "02/21 17:12", "push_tag": "→", "push_userid": "Rudy"}, {"push_content": "只有乳癌的一半 更不用說乳癌比大腸癌更容易發現", "push_ipdatetime": "02/21 17:13", "push_tag": "→", "push_userid": "nickdarren"}, {"push_content": "推分析", "push_ipdatetime": "02/21 17:21", "push_tag": "推", "push_userid": "howard172"}, {"push_content": "破底為下一波大買點", "push_ipdatetime": "02/21 17:23", "push_tag": "→", "push_userid": "bbs3379"}, {"push_content": "跟中華隊一樣雖敗遊龍", "push_ipdatetime": "02/21 17:28", "push_tag": "推", "push_userid": "Boyzone"}, {"push_content": "基亞是說藥證延後而已，他們也沒說失敗喔", "push_ipdatetime": "02/21 17:32", "push_tag": "→", "push_userid": "abuu0929"}, {"push_content": "藥證延後照樣是連續跌停，市場不會管你那麼多", "push_ipdatetime": "02/21 17:32", "push_tag": "→", "push_userid": "abuu0929"}, {"push_content": "太貴買不起拉 可以跌到兩百以下讓我進場玩一張嗎?", "push_ipdatetime": "02/21 17:34", "push_tag": "→", "push_userid": "tctv2002"}, {"push_content": "不管啦 明天生技股通通漲停就對了", "push_ipdatetime": "02/21 17:41", "push_tag": "推", "push_userid": "aquahau"}, {"push_content": "現在有些癌症藥本來就有爭對特殊基因表現的患者", "push_ipdatetime": "02/21 17:45", "push_tag": "推", "push_userid": "demonh311"}, {"push_content": "基亞還說影像送國外判讀 至今無下文…", "push_ipdatetime": "02/21 17:49", "push_tag": "推", "push_userid": "yilanism"}, {"push_content": "多軍每個都心驚膽顫", "push_ipdatetime": "02/21 17:53", "push_tag": "推", "push_userid": "suyisan"}, {"push_content": "推", "push_ipdatetime": "02/21 18:16", "push_tag": "推", "push_userid": "gg889g8"}, {"push_content": "對吼，基亞還沒放棄，只是我認為那個數據沒希望了", "push_ipdatetime": "02/21 18:22", "push_tag": "→", "push_userid": "Rudy"}, {"push_content": "浩鼎跌個幾根也正常，畢竟五年後上市，和兩年就上", "push_ipdatetime": "02/21 18:23", "push_tag": "→", "push_userid": "Rudy"}, {"push_content": "股價一定是差很多的", "push_ipdatetime": "02/21 18:23", "push_tag": "→", "push_userid": "Rudy"}, {"push_content": "如果浩頂真的弄出來 基亞就有希望了", "push_ipdatetime": "02/21 18:43", "push_tag": "推", "push_userid": "u770114"}, {"push_content": "總之現在股價681就是要你今天p<.05，沒過一定慘跌", "push_ipdatetime": "02/21 18:43", "push_tag": "→", "push_userid": "abuu0929"}, {"push_content": "其他生技的專業我們當然沒有專家學者了解", "push_ipdatetime": "02/21 18:43", "push_tag": "→", "push_userid": "abuu0929"}, {"push_content": "但分析那些對於市場來說，只能判斷他會跌到哪而已", "push_ipdatetime": "02/21 18:44", "push_tag": "→", "push_userid": "abuu0929"}, {"push_content": "覺得這技術要能達到上市的可能性降低不少", "push_ipdatetime": "02/21 19:01", "push_tag": "推", "push_userid": "cyora"}, {"push_content": "找出可以產生抗體的病人,那這顆藥還是可以賣錢.", "push_ipdatetime": "02/21 19:02", "push_tag": "推", "push_userid": "soulism"}, {"push_content": "賺多少,可能是看適用病人的範圍有多大", "push_ipdatetime": "02/21 19:03", "push_tag": "→", "push_userid": "soulism"}, {"push_content": "只要能賺三陰性的乳癌患者就賺暴了", "push_ipdatetime": "02/21 19:37", "push_tag": "推", "push_userid": "chungyao"}, {"push_content": "搞不好是佐劑引起的免疫反應，根本不是對glob H的專", "push_ipdatetime": "02/21 21:28", "push_tag": "推", "push_userid": "epicurious"}, {"push_content": "一免疫反應，事情才更大條...", "push_ipdatetime": "02/21 21:28", "push_tag": "→", "push_userid": "epicurious"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456043290.A.337.html"},
{"article_id": "M.1456045435.A.107", "article_title": "Re: [新聞] 浩鼎將變更設計 擴大三期臨床試驗", "author": "drt0422 (小蔡)", "board": "Stock", "content": "其實，現在去談論報導關於解盲成功與否的部分，我感覺不是真正該憂慮的。 現在主要問題是，如果一半以上的人未得到成功的答案就會鬆動，開始賣股； 另外認為不算不成功的人是否敢承接？如果不敢，會是什麼情況？ http://www.cmoney.tw/notes/notedetail.aspx?nid=15686 4百變1百，基亞連跌19根 賠最多錢的 10大苦主 一一點名看是哪幾位? 基亞(3176)連跌19根 小型股驚爆違約交割 實在太慘烈 基亞今天出現連續 第19根 跌停， 一家不賺錢的公司， 股價飆到470元 接著 股價 無量 從 4百元 跌到 1百元， 也算是另類奇觀 金主圈傳出被基亞套住的金額約350至400億元， 由於金主無法抽出投入基亞的資金， 資金出現缺口之後，只能大砍其他股票求現， 影響層面延燒，多檔中小型股甚至爆出違約交割， 今日遭打入跌停的中小型股持續增加 拖累OTC今日繼續破底 賠最多錢的：前 10大苦主 是那些人呢? 原本以為只是基亞單一事件的利空， 沒想到連金主圈都飽受其害， 這讓我很好奇 近半年狂買，但現在卻慘賠的 前10大苦主有哪些 於是我打開籌碼K線 並將統計天數選120(統計近半年來籌碼數據) (圖片略) 苦主1號：統一土城 虧損3.36億 統一土城 可以說是最大輸家， 近半年來，主力買超1618張全數慘套， 目前虧損最大，高達3.36億，堪稱輸家1 接著，我想用 統一土城 的地理位置來了解 是否為公司派的相關金主， 於是，我在統一土城點選右鍵選了主力地圖 發現統一土城主要位於土城區裕民路上 接著，我在主力地圖中輸入 基亞的大股東云辰(2390)， 看看這間統一土城是不是也有著墨， 果然， 基亞 苦主1號 所在地：統一土城 地點就在 云辰(2390) 隔壁， 因此推估 統一土城 很有可能就是 公司及相關外圍人士進出的 券商分點。 此外，云辰 自 基亞起跌的近一個月內， 云辰 賣超第一名 也是統一土城(請參考下圖) 可以感受到 因 基亞無量跌停的影響。 金主 為周轉資金，只好 先賣云辰套現， 這一波無量下跌，虧損最大的前 10位 還有： 苦主 2號：元大北屯 虧損1.81億 苦主 3號：台灣企銀民雄 虧損0.82億 苦主 4號：永豐金 虧損0.96億 苦主 5號：國票長城 虧損0.98億 苦主 6號：日盛 虧損 虧損0.59億 苦主 7號：元富府中 虧損0.62億 苦主 8號：凱基東勢 虧損0.83億 苦主 9號：大慶蘆洲 虧損0.44億 苦主10號：玉山板橋 虧損0.61億 親愛的投資朋友， 如果你手上還有基亞沒賣掉， 希望，看完以上10位苦主，能稍稍安慰你受傷的心靈。 這篇是基亞跌十九根之後出現的文章，裡面應該才是可以注意的。 如果資金受牽連，理論上會先摔生技類股，資金不足以現在來說可能跑金融營建。 在這種情況，我想外資就算認為有貢獻，也不會在類似吹泡沫的情況下承接4174。 而後，400點摔到113弄了19個營業日，這六百多會拖多少天？ 影響到哪邊？套在誰頭上？ 就算我手上沒半檔金融、營建與生技，仍然感覺多少會受到牽連柳 [emailprotected] @.. 紅塵作伴過的瀟瀟灑灑 策馬奔騰共享人世繁華 對酒當歌唱出心中喜悅 轟轟烈烈把握青春年華 補充一下： 剛剛突然想到前幾天關於台股散戶比重降低的新聞，看了一下。 截至2/19日4174的持股： 外資25801張(15.12%) 投信 1515張( 0.89%) 自營 352張( 0.21%) 12/18到1/8這段緩降似乎有消化些，重點是1/82/19進場的。 希望法人認為是還有機會就不會太慘 [emailprotected] @..", "date": "Sun Feb 21 17:03:46 2016", "ip": "1.163.109.123", "message_count": {"all": 24, "boo": 0, "count": 9, "neutral": 15, "push": 9}, "messages": [{"push_content": "好險我買3d列印", "push_ipdatetime": "02/21 17:06", "push_tag": "推", "push_userid": "evil7589"}, {"push_content": "我是塑化加網通，但覺得還是有可能，尤其日子拖著", "push_ipdatetime": "02/21 17:08", "push_tag": "→", "push_userid": "drt0422"}, {"push_content": "你籌碼系的?!", "push_ipdatetime": "02/21 17:22", "push_tag": "推", "push_userid": "bbs3379"}, {"push_content": "我是都看的吧，基本、技術、籌碼、消息都參考..", "push_ipdatetime": "02/21 17:31", "push_tag": "→", "push_userid": "drt0422"}, {"push_content": "不多說", "push_ipdatetime": "02/21 17:38", "push_tag": "推", "push_userid": "future2010"}, {"push_content": "崩", "push_ipdatetime": "02/21 17:42", "push_tag": "推", "push_userid": "bearian"}, {"push_content": "意思是說只要十大苦主通通不賣剩下的慘戶也起不了作", "push_ipdatetime": "02/21 18:09", "push_tag": "推", "push_userid": "aquahau"}, {"push_content": "用阿", "push_ipdatetime": "02/21 18:09", "push_tag": "→", "push_userid": "aquahau"}, {"push_content": "以4174外資這種持股 股票是要賣給自己嗎xd", "push_ipdatetime": "02/21 18:11", "push_tag": "→", "push_userid": "aquahau"}, {"push_content": "當然不是這意思囉，至少可以不用崩的太慘，一定程度", "push_ipdatetime": "02/21 18:14", "push_tag": "→", "push_userid": "drt0422"}, {"push_content": "時若外資認為是目標價，會出手做攤平的動作；全部在", "push_ipdatetime": "02/21 18:15", "push_tag": "→", "push_userid": "drt0422"}, {"push_content": "不理性跌停賣出、量又遠大於自己持股時，應該就沒承", "push_ipdatetime": "02/21 18:16", "push_tag": "→", "push_userid": "drt0422"}, {"push_content": "要謝謝阿宗 那時跌停7% 現在10% 所以會快一點", "push_ipdatetime": "02/21 18:16", "push_tag": "推", "push_userid": "False"}, {"push_content": "接的可能。不過以目前來說，機會渺茫 [email protected] @..", "push_ipdatetime": "02/21 18:17", "push_tag": "→", "push_userid": "drt0422"}, {"push_content": "哈哈哈哈，對喔！現在是10%，這想一下先...", "push_ipdatetime": "02/21 18:18", "push_tag": "→", "push_userid": "drt0422"}, {"push_content": "為什麼要特別研究啥時停殺@@? 想接嗎:)", "push_ipdatetime": "02/21 18:20", "push_tag": "推", "push_userid": "exrickey"}, {"push_content": "不是想接，是在想若這多少有牽連資金面的話，我的持", "push_ipdatetime": "02/21 18:23", "push_tag": "→", "push_userid": "drt0422"}, {"push_content": "股要不要在目標價前先了結，避免久了受牽連..", "push_ipdatetime": "02/21 18:23", "push_tag": "→", "push_userid": "drt0422"}, {"push_content": "此外，兵荒馬亂多少會影響計畫，這就討厭了 [email protected] @", "push_ipdatetime": "02/21 18:25", "push_tag": "→", "push_userid": "drt0422"}, {"push_content": "你說的是 我也很擔心會影響其他類股呢 快我等你", "push_ipdatetime": "02/21 18:25", "push_tag": "推", "push_userid": "exrickey"}, {"push_content": "因為我知道自己研究不出來XDDDD 怕的話短期先出吧", "push_ipdatetime": "02/21 18:26", "push_tag": "→", "push_userid": "exrickey"}, {"push_content": "快別這樣說@ [email protected] 我目前有個持股很接近目標價，頭痛中", "push_ipdatetime": "02/21 18:27", "push_tag": "→", "push_userid": "drt0422"}, {"push_content": "就先不貪了阿 研究這認真不怕沒機會的==!", "push_ipdatetime": "02/21 18:29", "push_tag": "推", "push_userid": "exrickey"}, {"push_content": "唉，這你就有所不知，或許明天決定後來po個心得..", "push_ipdatetime": "02/21 18:51", "push_tag": "→", "push_userid": "drt0422"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456045435.A.107.html"},
{"article_id": "M.1456046024.A.F65", "article_title": "[新聞] 巨人網絡史玉柱 重金衝手遊", "author": "STAV72 (刁民黨黨務主委)", "board": "Stock", "content": "1.原文連結(必須檢附)： http://goo.gl/3FhPI5 2.原文內容： 巨人網絡史玉柱 重金衝手遊 分享分享留言列印 AA 20160221 05:11 經濟日報 記者孫淑瑜綜合報導 http://imgur.com/Wb3jiYr 史玉柱小檔案 圖經濟日報提供 分享巨人網絡公司借殼世紀遊輪回歸A股市場，受到大陸證監會頻頻關注，巨人網絡董事 長史玉柱準備帶領全公司的研發高管聚焦精品手遊（手機遊戲）研發，還決定給研發人員 加薪，平均幅度在50%。 史玉柱的公司回歸A股，帶來公司轉戰手遊市場的強勢決心，還有全體研發人員的大好福 利。除了漲工資、給股票，對於巨人網絡內部管理出現的問題，史玉柱同樣也大刀闊斧的 進行改革。 2015年11月，史玉柱宣布直接辭去133名幹部，使幹部總數從160名大幅下降至27名，完成 公司扁平化管理制度與權力下放，為巨人在手遊戰略目標鋪平道路。 在2015年巨人年會上，史玉柱說：公司唯一的出路是研發出精品手遊。誰研發出精品， 公司就給該項目責任人發獎金發股票，使你身價過億。如果公司獎勵沒過億，我個人給你 補齊。 根據巨人網絡的公告，公司設立了約十個研發工作室，均由獨立製作人帶領，未來將在手 遊研發上採取百花齊放的戰略，強調巨人發展精品手遊的決心。 史玉柱在1991年成立巨人公司，1994年初，巨人大廈動工，當年史玉柱被提名為大陸十大 改革風雲人物，隔年就被富比世列為大陸富豪第八位，當年才33歲。 隔年，巨人大廈資金告急，史玉柱將保健品方面的全部資金調往巨人大廈，保健品業務因 資金抽血過量及管理不善，盛極而衰，巨人集團此時已名存實亡，只差沒有申請破產 。 然而，傳奇人物總是能在人生的谷底重新堅韌起來，2000年史玉柱再度創業，並在上海另 外申請註冊巨人公司，謀求上市，2006年就獲得大陸遊戲產業最具影響力人物獎。 2007年11月1日，史玉柱的巨人網絡集團公司成功登陸美國紐交所，總市值達到42億美元 ，成為在美國發行規模最大的大陸民營企業，史玉柱身價突破500億元。 京華時報這麼描述他：從一窮二白的創業青年，到全國排名第八的億萬富豪，再到負債 兩個多億的全國最窮的人，再到身家數十億元的資本家，史玉柱演繹的真實故事，情 節之豐富，命運之跌宕，超乎財經小說的想像。如今，巨人網絡面對監管單位的問詢， 承諾2016到2018年扣除非經常性損益後的淨利潤分別不低於10億元、12億元和15億元，而 這顯然不容易達成。 3.心得/評論(必需填寫)： 我一直覺得台灣缺乏恐怖遊戲的開發戰力是產業上的重大缺陷； 就拿最近的作品《佛萊迪的五夜驚魂》(Five Nights at Freddys)來說吧； 史葛 戈晃個人工作室前後出了四部賣座作品，2015年12月18日，由遊戲原作者 史葛 戈晃與Kira BreedWrigley聯合編寫，收錄系列全新故事的小說 《佛萊迪的五夜驚魂 銀色的雙眼》（Five Nights at Freddys: The Silver Eyes）， 將於Kindle平台上市，並透過亞馬遜公司推出按需求印刷的版本。 台灣加油點好嗎？這種本益比破表的標的物可不是隨處可見的...... ==========================此生必玩的恐怖系列作品========================== (SOMA)(Until Dawn)(Five Nights at Freddys)(Outlast)(Heavy Rain)(Dead Space) (Amnesia: The Dark Descent)(Siren: Blood Curse)(Silent Hill)(SIREN)(零系列) (The Evil Within)(BioShock)(戰慄突擊)(Alan Wake)(Emily want to play)(屍體派對) (RPG MAKER的魔女之家、IB、哥欲祟跟青鬼)(恐怖驚魂夜 忌火起草)(F.E.A.R)(薔薇守則) (狂氣古城)(Layers of fearSanitarium瘋人院)(Phantasmagoria)(Alien: Isolation) ", "date": "Sun Feb 21 17:13:39 2016", "ip": "114.45.60.15", "message_count": {"all": 8, "boo": 0, "count": 3, "neutral": 5, "push": 3}, "messages": [{"push_content": "沒空..  大家都在研究浩鼎", "push_ipdatetime": "02/21 17:16", "push_tag": "→", "push_userid": "TouSan"}, {"push_content": "一堆幹部不知道要幹啥用的  肥貓", "push_ipdatetime": "02/21 17:18", "push_tag": "推", "push_userid": "ZakuSIN"}, {"push_content": "手遊有精品?", "push_ipdatetime": "02/21 18:04", "push_tag": "→", "push_userid": "les0818"}, {"push_content": "手遊是坑殺一般人用的 以賺錢來說短期還不錯喔", "push_ipdatetime": "02/21 18:22", "push_tag": "推", "push_userid": "exrickey"}, {"push_content": "台灣手遊看多了 哪能像恐怖遊戲一樣10年後有人實況?", "push_ipdatetime": "02/21 19:04", "push_tag": "→", "push_userid": "STAV72"}, {"push_content": "如果族群設定上班族，至少每月可能會儲值199,族群是", "push_ipdatetime": "02/21 19:04", "push_tag": "推", "push_userid": "u48652004"}, {"push_content": "學生就難說了", "push_ipdatetime": "02/21 19:04", "push_tag": "→", "push_userid": "u48652004"}, {"push_content": "代理的問題也很大 就看神魔模式是否無法重現商機", "push_ipdatetime": "02/21 19:09", "push_tag": "→", "push_userid": "STAV72"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456046024.A.F65.html"},
{"article_id": "M.1456049295.A.194", "article_title": "[標的] 4174浩鼎 有推薦的認售權證嗎?", "author": "Hodge (霍奇)", "board": "Stock", "content": "1. 標的：4174浩鼎 2. 分類：都沒有認售權證要怎麼分類... 3. 正文： 各位股版的炒股專家大家好、大家安安 想請問浩鼎的認售權證，有人推薦哪檔比較有好康的嗎? 感謝各位大大熱心分享 4. 進退場機制：(停損價位/出場條件/長期投資) 同2. 請問散戶能借券嗎?", "date": "Sun Feb 21 18:08:11 2016", "ip": "140.116.138.202", "message_count": {"all": 29, "boo": 9, "count": 0, "neutral": 11, "push": 9}, "messages": [{"push_content": "浩鼎我記得沒有認售", "push_ipdatetime": "02/21 18:09", "push_tag": "→", "push_userid": "markban"}, {"push_content": "你有先查過嗎？", "push_ipdatetime": "02/21 18:09", "push_tag": "噓", "push_userid": "whitedeath"}, {"push_content": "http://www. 浩鼎認售.com", "push_ipdatetime": "02/21 18:12", "push_tag": "推", "push_userid": "yilanism"}, {"push_content": "都不做一點功課的嗎？？", "push_ipdatetime": "02/21 18:13", "push_tag": "噓", "push_userid": "bearian"}, {"push_content": "連簡單查詢都沒能力了,還是把錢省下來吃飯吧...", "push_ipdatetime": "02/21 18:15", "push_tag": "噓", "push_userid": "yosuke1984"}, {"push_content": "想問大大明天放空來的及嗎", "push_ipdatetime": "02/21 18:18", "push_tag": "噓", "push_userid": "clubbox"}, {"push_content": "我覺得做多勝算大！", "push_ipdatetime": "02/21 18:19", "push_tag": "→", "push_userid": "dapaochiu"}, {"push_content": "這檔散戶是要用啥空?", "push_ipdatetime": "02/21 18:20", "push_tag": "推", "push_userid": "rosefan"}, {"push_content": "借券", "push_ipdatetime": "02/21 18:22", "push_tag": "推", "push_userid": "ntunick"}, {"push_content": "欠噓", "push_ipdatetime": "02/21 18:25", "push_tag": "噓", "push_userid": "Beef"}, {"push_content": "變F-浩鼎了", "push_ipdatetime": "02/21 18:25", "push_tag": "推", "push_userid": "tom77588"}, {"push_content": "我不知道 f- 8 all in 這樣算嗎??", "push_ipdatetime": "02/21 18:32", "push_tag": "推", "push_userid": "fish19831012"}, {"push_content": "………", "push_ipdatetime": "02/21 18:39", "push_tag": "噓", "push_userid": "appleye"}, {"push_content": "連新手都知道要想空4174...", "push_ipdatetime": "02/21 19:03", "push_tag": "噓", "push_userid": "cloud701002"}, {"push_content": "別說浩鼎了，連其他生技股都沒認售了，之前基亞事", "push_ipdatetime": "02/21 19:21", "push_tag": "噓", "push_userid": "weivvv"}, {"push_content": "件，券商早學乖了，只開認購不開認售，超賤，根本違", "push_ipdatetime": "02/21 19:21", "push_tag": "→", "push_userid": "weivvv"}, {"push_content": "反比例原則，坑殺散戶，我建議要修法，認售認購必", "push_ipdatetime": "02/21 19:21", "push_tag": "→", "push_userid": "weivvv"}, {"push_content": "需相當比例，不然券商根本是穩賺不賠啊，還可以自己", "push_ipdatetime": "02/21 19:21", "push_tag": "→", "push_userid": "weivvv"}, {"push_content": "調隱波，法克...", "push_ipdatetime": "02/21 19:21", "push_tag": "→", "push_userid": "weivvv"}, {"push_content": "不能融資券沒有權證 買的人都是真槍實彈", "push_ipdatetime": "02/21 19:42", "push_tag": "推", "push_userid": "Boyzone"}, {"push_content": "有的話，我早就買滿，風險頂多吃膏，期望值好幾倍", "push_ipdatetime": "02/21 19:50", "push_tag": "推", "push_userid": "Elate"}, {"push_content": "沒有出權證啦", "push_ipdatetime": "02/21 19:56", "push_tag": "→", "push_userid": "tpjocl"}, {"push_content": "4105有 哈哈", "push_ipdatetime": "02/21 20:11", "push_tag": "推", "push_userid": "Lovefisher"}, {"push_content": "不懂權證發行條件 別來亂", "push_ipdatetime": "02/21 20:58", "push_tag": "推", "push_userid": "genius721105"}, {"push_content": "人多的地方不要去&沒做功課...", "push_ipdatetime": "02/21 21:15", "push_tag": "→", "push_userid": "jhsmr"}, {"push_content": "某樓腦子進水？發認售卷商不能避險是準備自己賠到", "push_ipdatetime": "02/21 21:47", "push_tag": "噓", "push_userid": "shihchinlun"}, {"push_content": "脫褲嗎", "push_ipdatetime": "02/21 21:47", "push_tag": "→", "push_userid": "shihchinlun"}, {"push_content": "板規1-4-2 請自D 改用標的發文或由板主砍文處份", "push_ipdatetime": "02/21 22:38", "push_tag": "→", "push_userid": "Sirius1812"}, {"push_content": "大哥 改標的要符合發文格式", "push_ipdatetime": "02/21 22:48", "push_tag": "→", "push_userid": "Sirius1812"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456049295.A.194.html"},
{"article_id": "M.1456050181.A.C18", "article_title": "Re: [新聞] 浩鼎將變更設計 擴大三期臨床試驗", "author": "ASPEED (STOCK)", "board": "Stock", "content": ": 解盲結果出來，有新聞說失敗，有新聞說成功，這也蠻有趣的。 : 其實就一件事，統計上的 P Value不夠好，所以失敗。 : 那成功的說法哪來的？ : 這就要牽扯到，Global H 在一般乳癌患者有反應的約佔 80%， : 對於剩下20%沒反應的，浩鼎的藥本來就一點用也沒有。 : 然後公司決定，既然有80%，那這次臨床就不篩選患者了。 : 再然後很不幸的，實驗組有 Global H反應的不夠多。 : 成功派的說法是，有產生抗體反應的人，藥效很好，比對照組好很多， : 統計P Value 也一定夠好。 : 所以張董有說，在台灣還是會去申請藥證， : 但是需要去溝通，看能不能改用篩選後的病人當結果。 : 恩恩，不過台灣不是重點，重點是美國後續的動作。 : 之前浩鼎有說，解盲的四種結果。 : 1.數據超好，直接申請藥證 : 2.數據不錯，補做小三期臨床 : 3.正常三期臨床 : 4.失敗，中止實驗 : 解盲前一般看法是2機率最高， : 這次後續顯然要走3路徑，算是不如預期的結果。 : 三期臨床燒錢燒時間，以現在股價來講，會有不少修正空間。 : 但我覺得不會像基亞那麼慘，基亞就真的是失敗， : 浩鼎修正一下臨床設計，篩一下病患，還是有戲唱的。 http://goo.gl/LWXp3B 根據文中論述 智擎 拿到美國藥證 股價223 寶齡 拿到美國藥證 股價136 太景 拿到台灣藥證 股價28.8(股本到底是多少 我真的不看不懂) 基亞 雙盲失敗 股價480150 浩鼎 解盲失敗 股價681??? 我不懂的是智擎 寶齡都 拿到藥證股價都不及浩鼎1/3 而浩鼎這是解盲失敗 還蠻多人看好東山在起??bala bala 數據很好 balabala 在篩選病人 balabala 在臨床三期 = =a?? 就算浩鼎解盲成功 股價要在噴也很難吧 看看智擎 寶齡吧..... 別跟自己的錢過不去 ", "date": "Sun Feb 21 18:22:59 2016", "ip": "111.251.89.48", "message_count": {"all": 12, "boo": 0, "count": 9, "neutral": 3, "push": 9}, "messages": [{"push_content": "別擔心，這檔這邊朋友買不起。", "push_ipdatetime": "02/21 18:24", "push_tag": "推", "push_userid": "ftrain"}, {"push_content": "把本夢比算進去，681算便宜了。", "push_ipdatetime": "02/21 18:24", "push_tag": "推", "push_userid": "abbei"}, {"push_content": "藥的市場不一樣，我的觀察啦", "push_ipdatetime": "02/21 18:24", "push_tag": "→", "push_userid": "hlchan"}, {"push_content": "哥買的是一個夢", "push_ipdatetime": "02/21 18:29", "push_tag": "推", "push_userid": "green26"}, {"push_content": "說不定跟大家想的不一樣", "push_ipdatetime": "02/21 18:29", "push_tag": "推", "push_userid": "iamthebest08"}, {"push_content": "我推薦台灣開放賭場 不然股票搞得跟賭博完全一樣...", "push_ipdatetime": "02/21 18:31", "push_tag": "→", "push_userid": "exrickey"}, {"push_content": "炒作罷了，浩呆沒那價值", "push_ipdatetime": "02/21 18:35", "push_tag": "推", "push_userid": "Bv999"}, {"push_content": "藥証也要看什麼藥的吧，冷門和熱門病的價值差很多", "push_ipdatetime": "02/21 18:43", "push_tag": "推", "push_userid": "aqua232"}, {"push_content": "裝睡的人永遠叫不醒  的 概念 ~", "push_ipdatetime": "02/21 19:00", "push_tag": "推", "push_userid": "f204137"}, {"push_content": "一種雖然失敗，卻學到經驗的說法", "push_ipdatetime": "02/21 19:23", "push_tag": "推", "push_userid": "evil7589"}, {"push_content": "炒股的抓去關好嗎", "push_ipdatetime": "02/21 19:30", "push_tag": "推", "push_userid": "BoyPlunger"}, {"push_content": "就光頭炒作", "push_ipdatetime": "02/21 20:19", "push_tag": "→", "push_userid": "purin3333"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456050181.A.C18.html"},
{"article_id": "M.1456051612.A.46E", "article_title": "[新聞] 浩鼎解盲 專家：科學上成功法規上失敗", "author": "au4au4j3fu4 (就i黑心掏空借殼轉機股)", "board": "Stock", "content": "1.原文連結(必須檢附)： https://goo.gl/u2xTrf 2.原文內容： （中央社記者韓婷婷台北2016年2月21日電）浩鼎 (4174) 抗乳癌新藥今天解盲，結果該 如何解讀？浩鼎董事長張念慈以出乎意料、跌破眼鏡的成功來詮釋，但專家及法人則 以科學上成功，法規上失敗來看待。 浩鼎下午舉行解盲結果重大訊息記者會，公布旗下抗乳癌新藥OBI822臨床二三期解盲 數據，初步結果顯示，用藥組和對照組相比，主要療效指標（primaryendpoint）未呈現 統計學上顯著意義。 浩鼎解盲結果不如原先市場預期，並未過關，但記者會間浩鼎經營團隊一再強調，對浩鼎 而言是個出乎意料、跌破眼鏡的成功，只是當初在臨床試驗的設計上不利，如果用新 的設計就過關了，讓在場記者也聽得有點混亂。 藥學博士、現任台灣工銀證券投顧協理的廖昌亮解釋，在法規上其實算是失敗的。但在科 學上是有進展的，某種層面上也算成功，對浩鼎跟醫學界是有意義的，可作為之後實驗設 計的參考。 廖昌亮表示，按照現有遊戲規則而言，解盲未過關是事實，在現有法規上是無法申請 藥證的，可以說是挫敗；但從現有的資訊判讀，在科學試驗的數據是有進展的，浩鼎應該 是看到其他次族群或細部結果，認為未來如果重新設計臨床試驗，成功的機率將大大拉高 。因此，從科學上而言是有進展的，因此浩鼎才會認為此次的臨床試驗是成功的。 就如張念慈在記者會上強調的，在此次第二/三期雙盲臨床試驗，傳統指標上雖然主要療 效指標未呈現統計學上顯著意義，但獲得相當豐富的資訊數據，有利接下來在全球三期臨 床試驗的設計。 在張念慈看來，這是一個非常成功的一次解盲，沒有所謂的挫敗，實際上達到的結果比預 期結果更好，數據是非常有意義的數據。他認為，對於全球三期臨床試驗的進度不會有延 宕，且讓浩鼎在下階段三期臨床試驗有更明確的方向。 浩鼎總經理黃秀美表示，浩鼎會根據這次解盲結果的發現，積極展開下階段的佈局及策略 ，除了將按原訂計劃與美國食品藥物管理署(FDA)、歐洲藥物管理局(EMA)就全球第三期臨 床試驗計劃協商外，也將和台灣食藥署(TFDA)展開諮商會議，並申請前往國際知名醫學會 及重要醫學期刊論文發表。 黃秀美表示，浩鼎也已經送件申請在6月份舉行的美國腫瘤醫學年會(ASCO)發表，將這次 解盲完整數據在發表會上發表。 3.心得/評論(必需填寫)： 有點混亂 意思就是 浩鼎董事長打臉所有統計學教授? 少數幾個有效用的極端值 代表浩鼎的疫苗是有效的?? ", "date": "Sun Feb 21 18:46:48 2016", "ip": "42.79.29.202", "message_count": {"all": 95, "boo": 11, "count": 32, "neutral": 41, "push": 43}, "messages": [{"push_content": "ASCO...", "push_ipdatetime": "02/21 18:49", "push_tag": "推", "push_userid": "WANG122122"}, {"push_content": "這樣凹有點難看 XD", "push_ipdatetime": "02/21 18:49", "push_tag": "→", "push_userid": "Altair"}, {"push_content": "科學上成功->醫學    法規上成功->股價", "push_ipdatetime": "02/21 18:49", "push_tag": "→", "push_userid": "ZakuSIN"}, {"push_content": "沒效就沒效在那邊扯", "push_ipdatetime": "02/21 18:49", "push_tag": "噓", "push_userid": "angelaeric24"}, {"push_content": "http://udn.com/news/story/6/1515413", "push_ipdatetime": "02/21 18:49", "push_tag": "推", "push_userid": "d147258"}, {"push_content": "所以說對它們來說跌破眼鏡的成功都沒辦法過關嗎？", "push_ipdatetime": "02/21 18:50", "push_tag": "推", "push_userid": "jakkx"}, {"push_content": "張董:沒賣就不算輸 請大家長期投資", "push_ipdatetime": "02/21 18:50", "push_tag": "噓", "push_userid": "intotheman"}, {"push_content": "這跟王雪紅有什麼差別", "push_ipdatetime": "02/21 18:50", "push_tag": "推", "push_userid": "twobrother20"}, {"push_content": "前面就有人說過了啊 硬要拿少數幾個說有效 成本根", "push_ipdatetime": "02/21 18:51", "push_tag": "→", "push_userid": "wintxa"}, {"push_content": "本入不敷出", "push_ipdatetime": "02/21 18:51", "push_tag": "→", "push_userid": "wintxa"}, {"push_content": "那大概要天元突破的成功才能過關了…", "push_ipdatetime": "02/21 18:52", "push_tag": "推", "push_userid": "jakkx"}, {"push_content": "那改遊戲規則就過惹Q.Q", "push_ipdatetime": "02/21 18:54", "push_tag": "→", "push_userid": "coyoteY"}, {"push_content": "我肉體上出軌 精神上還是愛你得!", "push_ipdatetime": "02/21 18:56", "push_tag": "→", "push_userid": "endlesswaltz"}, {"push_content": "尹董...會不會出手呢？", "push_ipdatetime": "02/21 18:58", "push_tag": "→", "push_userid": "hun410705"}, {"push_content": "那董事長超乎預期的成功 是市場的預期嗎?", "push_ipdatetime": "02/21 18:59", "push_tag": "推", "push_userid": "EasternAsh"}, {"push_content": "統計無顯著關係.就是..失敗啊", "push_ipdatetime": "02/21 18:59", "push_tag": "推", "push_userid": "yanki826"}, {"push_content": "簡單來說就是這次是beta版，正式版還要等下次。", "push_ipdatetime": "02/21 19:01", "push_tag": "推", "push_userid": "u48652004"}, {"push_content": "我看是「出乎意料、跌破眼鏡的失敗」吧…", "push_ipdatetime": "02/21 19:02", "push_tag": "→", "push_userid": "cyora"}, {"push_content": "這和每一次台灣棒球國際賽對強國的賽後說法都很像", "push_ipdatetime": "02/21 19:03", "push_tag": "推", "push_userid": "EasternAsh"}, {"push_content": "真的出乎意料的成功 那為什麼一開始不篩選XD?", "push_ipdatetime": "02/21 19:04", "push_tag": "→", "push_userid": "EasternAsh"}, {"push_content": "那表示一開始浩鼎對市場對自己的自信是很高的", "push_ipdatetime": "02/21 19:04", "push_tag": "→", "push_userid": "EasternAsh"}, {"push_content": "講的好像公司都不知道自己的市值一樣 真是不要臉", "push_ipdatetime": "02/21 19:07", "push_tag": "推", "push_userid": "yyyyy"}, {"push_content": "管你科學上還是法規上成不成功 這樣的股價就是炒作", "push_ipdatetime": "02/21 19:08", "push_tag": "→", "push_userid": "yyyyy"}, {"push_content": "出來的產物 難道公司不用負責嗎", "push_ipdatetime": "02/21 19:08", "push_tag": "→", "push_userid": "yyyyy"}, {"push_content": "話說浩鼎最新市值約一千多億的樣子?", "push_ipdatetime": "02/21 19:09", "push_tag": "推", "push_userid": "EasternAsh"}, {"push_content": "連我家門口賣菜阿嬤都說要放空浩鼎 你說會跌嗎？笑", "push_ipdatetime": "02/21 19:09", "push_tag": "噓", "push_userid": "KadourZiani"}, {"push_content": "死", "push_ipdatetime": "02/21 19:09", "push_tag": "→", "push_userid": "KadourZiani"}, {"push_content": "若一千億支撐出乎意料超乎預期的成功的話 我也服了", "push_ipdatetime": "02/21 19:10", "push_tag": "→", "push_userid": "EasternAsh"}, {"push_content": "被有心人打著招牌大肆拉抬的 某知名集團和某準諾貝", "push_ipdatetime": "02/21 19:10", "push_tag": "→", "push_userid": "yyyyy"}, {"push_content": "你能空我也佩服", "push_ipdatetime": "02/21 19:10", "push_tag": "→", "push_userid": "cloud7515"}, {"push_content": "爾奶酪捲得主 不需要負責嗎 科科", "push_ipdatetime": "02/21 19:11", "push_tag": "→", "push_userid": "yyyyy"}, {"push_content": "賣菜阿嬤如果可以借券放空 表示來頭也不簡單", "push_ipdatetime": "02/21 19:11", "push_tag": "→", "push_userid": "EasternAsh"}, {"push_content": "我家的黃金小獵犬星期四漲停就不斷的對我亂吠", "push_ipdatetime": "02/21 19:12", "push_tag": "→", "push_userid": "yyyyy"}, {"push_content": "強者我朋友那時候就手癢空了100張 科科", "push_ipdatetime": "02/21 19:12", "push_tag": "→", "push_userid": "yyyyy"}, {"push_content": "現在到處問人說覺得會連幾拉幾 幹", "push_ipdatetime": "02/21 19:13", "push_tag": "→", "push_userid": "yyyyy"}, {"push_content": "不凹一下怎麼讓大戶跑路", "push_ipdatetime": "02/21 19:16", "push_tag": "推", "push_userid": "kamelot"}, {"push_content": "不能信用交易你朋友是怎麼空的 地下交易所？", "push_ipdatetime": "02/21 19:16", "push_tag": "→", "push_userid": "cloud7515"}, {"push_content": "認售", "push_ipdatetime": "02/21 19:17", "push_tag": "推", "push_userid": "KadourZiani"}, {"push_content": "基亞翻版來囉，已提前布局其他新藥股空單，一起跌爆", "push_ipdatetime": "02/21 19:17", "push_tag": "噓", "push_userid": "weivvv"}, {"push_content": "吧，就等這一刻了！", "push_ipdatetime": "02/21 19:17", "push_tag": "→", "push_userid": "weivvv"}, {"push_content": "生技王子  哩來公跨脈", "push_ipdatetime": "02/21 19:20", "push_tag": "推", "push_userid": "GoOdGaMe"}, {"push_content": "王榮旭XD", "push_ipdatetime": "02/21 19:21", "push_tag": "推", "push_userid": "BoyPlunger"}, {"push_content": "推 肉體上出軌 精神上還是愛你", "push_ipdatetime": "02/21 19:22", "push_tag": "推", "push_userid": "KadourZiani"}, {"push_content": "Xddd", "push_ipdatetime": "02/21 19:22", "push_tag": "→", "push_userid": "KadourZiani"}, {"push_content": "科科 誰說不能空 有辦法的人就是可以 空到你發麻", "push_ipdatetime": "02/21 19:23", "push_tag": "推", "push_userid": "yyyyy"}, {"push_content": "生技王子有參加這次的解盲嗎?", "push_ipdatetime": "02/21 19:23", "push_tag": "推", "push_userid": "siaoyen"}, {"push_content": "科科 一解盲一堆做空神人都出現了", "push_ipdatetime": "02/21 19:26", "push_tag": "推", "push_userid": "rjie"}, {"push_content": "一堆手上沒貨的也無法去空的人在這嚼舌根", "push_ipdatetime": "02/21 19:26", "push_tag": "推", "push_userid": "chungyao"}, {"push_content": "空100張？認售？我笑了", "push_ipdatetime": "02/21 19:27", "push_tag": "→", "push_userid": "chungyao"}, {"push_content": "我手上還真的沒這支 完全看戲心態 場內的人保重", "push_ipdatetime": "02/21 19:27", "push_tag": "→", "push_userid": "Lineage5415"}, {"push_content": "統計上不顯著就是不顯著 硬要拿少數例子說成功 那就", "push_ipdatetime": "02/21 19:28", "push_tag": "噓", "push_userid": "cliff159357"}, {"push_content": "不用統計了好嗎????", "push_ipdatetime": "02/21 19:28", "push_tag": "→", "push_userid": "cliff159357"}, {"push_content": "這種公司就是台灣未來的發展方向???", "push_ipdatetime": "02/21 19:29", "push_tag": "→", "push_userid": "wuklean"}, {"push_content": "失敗 才在那邊玩文字遊戲 真成功 早就大肆宣傳 讓股", "push_ipdatetime": "02/21 19:30", "push_tag": "→", "push_userid": "cliff159357"}, {"push_content": "問小英", "push_ipdatetime": "02/21 19:31", "push_tag": "→", "push_userid": "BoyPlunger"}, {"push_content": "價噴更高 浩鼎股本這麼小 當國外花幾千億研發都是白", "push_ipdatetime": "02/21 19:31", "push_tag": "→", "push_userid": "cliff159357"}, {"push_content": "癡嗎 台灣都這麼少錢能研究出個什麼鳥蛋啦", "push_ipdatetime": "02/21 19:32", "push_tag": "→", "push_userid": "cliff159357"}, {"push_content": "大戶哪這麼蠢 要跑早跑了還等到解盲", "push_ipdatetime": "02/21 19:32", "push_tag": "推", "push_userid": "lovecut"}, {"push_content": "看台灣生技產品都是保健食品 浩鼎可能? 呵呵", "push_ipdatetime": "02/21 19:33", "push_tag": "→", "push_userid": "cliff159357"}, {"push_content": "人家有潤泰當靠山部會崩拉", "push_ipdatetime": "02/21 19:34", "push_tag": "推", "push_userid": "BoyPlunger"}, {"push_content": "=============================推文小心阿 明天驗證", "push_ipdatetime": "02/21 19:34", "push_tag": "推", "push_userid": "Lineage5415"}, {"push_content": "不就是一堆沒跑掉的在喊噴噴！", "push_ipdatetime": "02/21 19:36", "push_tag": "推", "push_userid": "bearian"}, {"push_content": "台股通常越爛越噴 這是也會嗎?", "push_ipdatetime": "02/21 19:37", "push_tag": "噓", "push_userid": "vector210"}, {"push_content": "還是看戲比較好 看情況撿尸", "push_ipdatetime": "02/21 19:38", "push_tag": "推", "push_userid": "hjgx"}, {"push_content": "意思就是我們大了好幾隻全壘打 但是都界外球", "push_ipdatetime": "02/21 19:43", "push_tag": "推", "push_userid": "Boyzone"}, {"push_content": "嘴砲空的不要出來秀下限好嗎", "push_ipdatetime": "02/21 19:44", "push_tag": "→", "push_userid": "future2010"}, {"push_content": "用新的設計來解讀就成功 跟先射箭再畫靶心有啥兩樣", "push_ipdatetime": "02/21 19:46", "push_tag": "→", "push_userid": "wildwoof"}, {"push_content": "好啦 其實可以發一篇paper 啦", "push_ipdatetime": "02/21 19:48", "push_tag": "推", "push_userid": "elijah2012"}, {"push_content": "拿個諾貝爾醫學獎也不錯啦........只是股價還是跌。", "push_ipdatetime": "02/21 19:50", "push_tag": "推", "push_userid": "abbei"}, {"push_content": "失敗當然可以發paper 告訴別人這條路不好走 請改道", "push_ipdatetime": "02/21 19:56", "push_tag": "推", "push_userid": "b1izzard2000"}, {"push_content": "A good lesson learn!", "push_ipdatetime": "02/21 20:00", "push_tag": "推", "push_userid": "gingsow"}, {"push_content": "失敗當然有意義，告訴大家別重蹈覆轍", "push_ipdatetime": "02/21 20:01", "push_tag": "→", "push_userid": "gingsow"}, {"push_content": "好啦好啦，明天給你吃紅棍子拉", "push_ipdatetime": "02/21 20:08", "push_tag": "推", "push_userid": "rickcoo"}, {"push_content": "這樣講只會讓一些人懷抱希望而已 崩崩無誤", "push_ipdatetime": "02/21 20:23", "push_tag": "推", "push_userid": "VISA01"}, {"push_content": "講那麼多 還不是要崩", "push_ipdatetime": "02/21 20:31", "push_tag": "推", "push_userid": "ikj"}, {"push_content": "解釋：感謝對科學上的貢獻，但還是先跌十根跌停", "push_ipdatetime": "02/21 20:52", "push_tag": "推", "push_userid": "kkkkk9"}, {"push_content": "推樓上，買650的浩鼎是為了噴到1000", "push_ipdatetime": "02/21 20:59", "push_tag": "推", "push_userid": "dahlia7357"}, {"push_content": "騙笑耶 以為大家都沒念過書阿...", "push_ipdatetime": "02/21 20:59", "push_tag": "推", "push_userid": "FSGuitar"}, {"push_content": "重新設計是想要設計一個更容易顯助的方法吧", "push_ipdatetime": "02/21 21:00", "push_tag": "→", "push_userid": "FSGuitar"}, {"push_content": "快逃啊", "push_ipdatetime": "02/21 21:07", "push_tag": "→", "push_userid": "woods0598"}, {"push_content": "18上台砸5000億進去生技就安啦", "push_ipdatetime": "02/21 21:22", "push_tag": "推", "push_userid": "kauw"}, {"push_content": "簡單的說  就是失敗了", "push_ipdatetime": "02/21 21:45", "push_tag": "推", "push_userid": "jerrylin"}, {"push_content": "一堆人還是硬凹看漲，算了，裝睡的人真的叫不醒..", "push_ipdatetime": "02/21 21:50", "push_tag": "推", "push_userid": "bearian"}, {"push_content": "先跌七成再說", "push_ipdatetime": "02/21 21:59", "push_tag": "推", "push_userid": "smalmal"}, {"push_content": "越爛越噴", "push_ipdatetime": "02/21 22:22", "push_tag": "推", "push_userid": "WilliamLFY"}, {"push_content": "台灣的生技股幾乎都是炒作和炒夢，想想看憑那些公司", "push_ipdatetime": "02/21 22:22", "push_tag": "噓", "push_userid": "megalink"}, {"push_content": "裡的研發人員素質若真能研發出什麼東東，那美國輝", "push_ipdatetime": "02/21 22:23", "push_tag": "→", "push_userid": "megalink"}, {"push_content": "瑞、默沙東等一干大藥廠裡集合全世界的頂尖研發人才", "push_ipdatetime": "02/21 22:23", "push_tag": "→", "push_userid": "megalink"}, {"push_content": "都可以解僱了啦", "push_ipdatetime": "02/21 22:23", "push_tag": "→", "push_userid": "megalink"}, {"push_content": "超乎預期的成功的把股票都高點出貨了", "push_ipdatetime": "02/22 00:30", "push_tag": "推", "push_userid": "SweetLee"}, {"push_content": "生技都這樣，能挖到寶不容易", "push_ipdatetime": "02/22 06:24", "push_tag": "推", "push_userid": "krishuang"}, {"push_content": "反正有錯絕對是別人的錯", "push_ipdatetime": "02/22 15:00", "push_tag": "噓", "push_userid": "knives"}, {"push_content": "統計上沒過，就是沒過啊！", "push_ipdatetime": "02/22 22:44", "push_tag": "噓", "push_userid": "moshear"}, {"push_content": "股價上的失敗", "push_ipdatetime": "02/22 23:29", "push_tag": "噓", "push_userid": "c3502285"}, {"push_content": "這年頭廢物都自稱專家", "push_ipdatetime": "02/23 11:05", "push_tag": "噓", "push_userid": "SkyShih"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456051612.A.46E.html"},
{"article_id": "M.1456052640.A.5E5", "article_title": "Re: [新聞] 浩鼎解盲 專家：科學上成功法規上失敗", "author": "drt0422 (小蔡)", "board": "Stock", "content": "看到這篇，我還真希望他是真的：真的有效用。 但很可惜，專家法人那句法規上失敗就是問題所在。 : 1.原文連結(必須檢附)： : https://goo.gl/u2xTrf : 2.原文內容： : （中央社記者韓婷婷台北2016年2月21日電）浩鼎 (4174) 抗乳癌新藥今天解盲，結果該 : 如何解讀？浩鼎董事長張念慈以出乎意料、跌破眼鏡的成功來詮釋，但專家及法人則 : 以科學上成功，法規上失敗來看待。 : 浩鼎下午舉行解盲結果重大訊息記者會，公布旗下抗乳癌新藥OBI822臨床二三期解盲 : 數據，初步結果顯示，用藥組和對照組相比，主要療效指標（primaryendpoint）未呈現 : 統計學上顯著意義。 : 浩鼎解盲結果不如原先市場預期，並未過關，但記者會間浩鼎經營團隊一再強調，對浩鼎 : 而言是個出乎意料、跌破眼鏡的成功，只是當初在臨床試驗的設計上不利，如果用新 : 的設計就過關了，讓在場記者也聽得有點混亂。 : 藥學博士、現任台灣工銀證券投顧協理的廖昌亮解釋，在法規上其實算是失敗的。但在科 : 學上是有進展的，某種層面上也算成功，對浩鼎跟醫學界是有意義的，可作為之後實驗設 : 計的參考。 : 廖昌亮表示，按照現有遊戲規則而言，解盲未過關是事實，在現有法規上是無法申請 : 藥證的，可以說是挫敗；但從現有的資訊判讀，在科學試驗的數據是有進展的，浩鼎應該 : 是看到其他次族群或細部結果，認為未來如果重新設計臨床試驗，成功的機率將大大拉高 : 。因此，從科學上而言是有進展的，因此浩鼎才會認為此次的臨床試驗是成功的。 : 就如張念慈在記者會上強調的，在此次第二/三期雙盲臨床試驗，傳統指標上雖然主要療 : 效指標未呈現統計學上顯著意義，但獲得相當豐富的資訊數據，有利接下來在全球三期臨 : 床試驗的設計。 : 在張念慈看來，這是一個非常成功的一次解盲，沒有所謂的挫敗，實際上達到的結果比預 : 期結果更好，數據是非常有意義的數據。他認為，對於全球三期臨床試驗的進度不會有延 : 宕，且讓浩鼎在下階段三期臨床試驗有更明確的方向。 寫論文的時候，同學與教授們都會說：你就寫、就貼，就算有那麼一點， 也是在這個區塊有所貢獻。 所以，他們說的也沒有錯，在醫學上有貢獻。 : 浩鼎總經理黃秀美表示，浩鼎會根據這次解盲結果的發現，積極展開下階段的佈局及策略 : ，除了將按原訂計劃與美國食品藥物管理署(FDA)、歐洲藥物管理局(EMA)就全球第三期臨 : 床試驗計劃協商外，也將和台灣食藥署(TFDA)展開諮商會議，並申請前往國際知名醫學會 : 及重要醫學期刊論文發表。 : 黃秀美表示，浩鼎也已經送件申請在6月份舉行的美國腫瘤醫學年會(ASCO)發表，將這次 : 解盲完整數據在發表會上發表。 發表，非常好，這除了在醫學上有貢獻之外，還能讓人期待某天會有救。 病人全世界那麼多，獨一無二的藥問世，光13億的對岸每十人送一元，就1.3億； 在醫學上的貢獻無人能及，當然是成功。 好玩的是，在法令上你不能過關販賣，就不能變錢；沒有可能獲利，管你有貢獻柳？ 大把錢屯在裡面相信你第三次實驗投藥，但有人利息在跑不能等要賣，我就算願意 相信你也沒辦法看著錢一天天消失的柳.. 市場看的就是藥能變成錢啊大哥 如果那法規上的失敗是由法人或專家所表態的明確語句，這不能變成錢的事實， 很難去正面看待明天的開盤 [emailprotected] @.. 紅塵作伴過的瀟瀟灑灑 策馬奔騰共享人世繁華 對酒當歌唱出心中喜悅 轟轟烈烈把握青春年華 精彩但株連甚廣就不好了.. 上次一張三十萬，這次搞不好五十萬，散戶撐不太住的.. 其一是沒得放空，其二是明天起見分曉。 反正我手機自選群組看到新聞後就加入了 [emailprotected] @.. 就是為了緩解責任，與期待讓部分人認為成功而不賣股。 真的？那好事情啊但明天就知道真狂跌的話有沒有量了 [emailprotected] @.. 真這樣他應該沒注意到浩頂4174代表的是死一起死 [emailprotected] @.. 可能免不了 [emailprotected] @.. 五支菸都會出現吧.. 其實，我真的希望明天之後漲不停，或者不跌停就好。 這錢沒的賺沒差，股市穩定比較重要。 這是沒有錯，本來就是有貢獻的。 目前重點在於，這消息造成股價異常的推升，期待所堆積出來的問題， 不單單只有雙手一攤、翻了瞪眼這麼簡單。 死外資、死投信等還好，有錢找別的標的賺回來、來不及直接提列損失， 持股散戶、因為資金流動而影響到的他股散戶，這牽連就不理想了。", "date": "Sun Feb 21 19:03:48 2016", "ip": "1.163.109.123", "message_count": {"all": 19, "boo": 2, "count": 2, "neutral": 13, "push": 4}, "messages": [{"push_content": "去年7月 基亞也很精彩~", "push_ipdatetime": "02/21 19:09", "push_tag": "→", "push_userid": "f204137"}, {"push_content": "別人法規都可以過，在這邊扯法規有問題", "push_ipdatetime": "02/21 19:11", "push_tag": "噓", "push_userid": "angelaeric24"}, {"push_content": "沒錯，說法規是牽拖，因為答案就是沒過，怕引發跌停", "push_ipdatetime": "02/21 19:14", "push_tag": "→", "push_userid": "drt0422"}, {"push_content": "效應跟推責任而說出來的。", "push_ipdatetime": "02/21 19:14", "push_tag": "→", "push_userid": "drt0422"}, {"push_content": "我家菲傭都問我要怎麼放空浩鼎了 會崩？", "push_ipdatetime": "02/21 19:20", "push_tag": "推", "push_userid": "KadourZiani"}, {"push_content": "解盲不過就是不過，為何模糊焦點，真的讓人混亂難", "push_ipdatetime": "02/21 19:20", "push_tag": "噓", "push_userid": "sbj0623"}, {"push_content": "解", "push_ipdatetime": "02/21 19:20", "push_tag": "→", "push_userid": "sbj0623"}, {"push_content": "最好笑的是必富網一堆人說成功，還說越跌越買，哈", "push_ipdatetime": "02/21 19:25", "push_tag": "→", "push_userid": "evil7589"}, {"push_content": "哈", "push_ipdatetime": "02/21 19:25", "push_tag": "→", "push_userid": "evil7589"}, {"push_content": "最好壓身家買，連房子都抵押去買，標準賭徒心態", "push_ipdatetime": "02/21 19:25", "push_tag": "→", "push_userid": "evil7589"}, {"push_content": "KadourZiani 你家路口阿罵 菲傭 有沒有一起空好空滿", "push_ipdatetime": "02/21 19:27", "push_tag": "推", "push_userid": "Lineage5415"}, {"push_content": "先來個3根", "push_ipdatetime": "02/21 19:27", "push_tag": "→", "push_userid": "ifay"}, {"push_content": "Xdddd 我家菲傭上次經過市場 聽到有個股票叫做浩鼎", "push_ipdatetime": "02/21 19:28", "push_tag": "→", "push_userid": "KadourZiani"}, {"push_content": "就是你，哈哈哈，我當場嚇了一跳， ...", "push_ipdatetime": "02/21 19:31", "push_tag": "推", "push_userid": "KadourZiani"}, {"push_content": "原來開玩笑", "push_ipdatetime": "02/21 19:33", "push_tag": "→", "push_userid": "KadourZiani"}, {"push_content": "=========================推文小心阿 明天回頭驗證", "push_ipdatetime": "02/21 19:35", "push_tag": "→", "push_userid": "Lineage5415"}, {"push_content": "失敗 對於科學研究來說的確是一種成功 別重蹈覆轍", "push_ipdatetime": "02/21 19:43", "push_tag": "推", "push_userid": "future2010"}, {"push_content": "明天就說是因為馬囧執政天怒人怨解盲才沒過的就好了", "push_ipdatetime": "02/21 21:33", "push_tag": "→", "push_userid": "sonatafm2"}, {"push_content": "等到新政府上台絕對不用解直接就過, 卍解!", "push_ipdatetime": "02/21 21:34", "push_tag": "→", "push_userid": "sonatafm2"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456052640.A.5E5.html"},
{"article_id": "M.1456054364.A.DD8", "article_title": "[新聞] 謝金河：浩鼎解盲未過 代誌大條", "author": "kof70380 (小隆)", "board": "Stock", "content": "1.原文連結(必須檢附)： http://udn.com/news/story/6/1515765 2.原文內容： 財金文化董事長謝金河在臉書指出，上次解盲未過的生技股基亞，連跌20支跌停板； 這次浩鼎解盲未過，如果重蹈基亞覆轍，恐怕是大災難，希望這樣的事別發生。 浩鼎下午舉行解盲結果重大訊息記者會，公布旗下抗乳癌新藥OBI822臨床二三期解 盲數據，初步結果顯示，用藥組和對照組相比，主要療效指標（primaryendpoint）未呈現 統計學上顯著意義。不過，浩鼎認為，雖然以當初在臨床試驗的設計上不利，但如果用新 的設計就過關了。 謝金河說，全市場今天全都聚焦在浩鼎解盲的消息，結果是解盲未過，這個消息對股 價衝擊多大？恐怕不能小覷。他強調，上次解盲的重頭戲是基亞，在市場期待中，基亞股 價拉到新台幣486元，解盲未過，基亞股價暴跌20支跌停板，最後跌到68元，市值從674億 元掉到94.3億元，投資人損失慘重。 這一波浩鼎解盲，他說，市場打著潤泰集團總裁尹衍樑、中央研究院院長翁啟惠的招 牌，大肆炒作，將股價拉升到755元，市場喊價上千元。一家乳癌新藥公司在解盲之前，市 值達40億美元，這是十分驚人的高價。 謝金河表示，曾要求同事找出目前市值40億美元的生技公司，到底長成什麼模樣？結 果大多數是有營收、獲利的公司。浩鼎在股價681元，市值1162億元之際解盲，只能說公司 太大膽，沒有把投資人風險考量在裡面，且任令市場人士炒作。 3.心得/評論(必需填寫)： 剛剛看聯合新聞網即時新聞第一名點閱率竟是浩鼎解盲，可見不少人有該股票吧不知道 基亞盛況會不會重演？ ", "date": "Sun Feb 21 19:32:40 2016", "ip": "36.239.125.188", "message_count": {"all": 63, "boo": 14, "count": 4, "neutral": 31, "push": 18}, "messages": [{"push_content": "崩崩崩 嘎啦欸欸", "push_ipdatetime": "02/21 19:34", "push_tag": "→", "push_userid": "AceDuck"}, {"push_content": "這位專門馬後砲的謝先生，之前不是大力喊進生技股?", "push_ipdatetime": "02/21 19:34", "push_tag": "噓", "push_userid": "redsaizu"}, {"push_content": "還是說喊100次讓你中1次就能稱作專家？", "push_ipdatetime": "02/21 19:35", "push_tag": "→", "push_userid": "redsaizu"}, {"push_content": "=============================他看空浩呆 訊號來惹", "push_ipdatetime": "02/21 19:36", "push_tag": "→", "push_userid": "Lineage5415"}, {"push_content": "生技會變成繃繃的領頭羊嗎??", "push_ipdatetime": "02/21 19:36", "push_tag": "推", "push_userid": "AlexLeee"}, {"push_content": "社長最會落井下石", "push_ipdatetime": "02/21 19:37", "push_tag": "推", "push_userid": "Boyzone"}, {"push_content": "羊定了", "push_ipdatetime": "02/21 19:37", "push_tag": "推", "push_userid": "TouSan"}, {"push_content": "事後才說", "push_ipdatetime": "02/21 19:38", "push_tag": "噓", "push_userid": "aboveground"}, {"push_content": "噓謝金河", "push_ipdatetime": "02/21 19:39", "push_tag": "噓", "push_userid": "Granadilla"}, {"push_content": "那麽佛心，怎不早說", "push_ipdatetime": "02/21 19:39", "push_tag": "→", "push_userid": "aboveground"}, {"push_content": "看到基亞嚇死我了", "push_ipdatetime": "02/21 19:39", "push_tag": "噓", "push_userid": "Crushredkiss"}, {"push_content": "火車過了才吹哨, 蟹老闆的專長", "push_ipdatetime": "02/21 19:40", "push_tag": "推", "push_userid": "slippers"}, {"push_content": "完蛋了，反指標確立。", "push_ipdatetime": "02/21 19:43", "push_tag": "推", "push_userid": "borry6299"}, {"push_content": "大誌大條？不會啊，我等著看好戲，超爽的", "push_ipdatetime": "02/21 19:44", "push_tag": "→", "push_userid": "onok"}, {"push_content": "看到投機人賠錢 超爽的 根本是賭博", "push_ipdatetime": "02/21 19:45", "push_tag": "→", "push_userid": "onok"}, {"push_content": "這是願賭服輸的概念啊 認命吧", "push_ipdatetime": "02/21 19:46", "push_tag": "→", "push_userid": "onok"}, {"push_content": "拿基亞比浩鼎。。。。謝先生也蠻厲害。。。雖然我", "push_ipdatetime": "02/21 19:47", "push_tag": "噓", "push_userid": "bluce2006"}, {"push_content": "空手。但浩鼎結果還是正面意義。。。。", "push_ipdatetime": "02/21 19:47", "push_tag": "→", "push_userid": "bluce2006"}, {"push_content": "上次基亞扯出一個胖達人,這次不知道有哪些金主", "push_ipdatetime": "02/21 19:48", "push_tag": "→", "push_userid": "guardian93"}, {"push_content": "台灣根本沒發展生技的資金、市場、人材", "push_ipdatetime": "02/21 19:48", "push_tag": "噓", "push_userid": "redsaizu"}, {"push_content": "請蔡英文政府別再浪費錢了支持了", "push_ipdatetime": "02/21 19:48", "push_tag": "→", "push_userid": "redsaizu"}, {"push_content": "反而工業4.0台灣都無動於衷，這才是改革台灣工業的", "push_ipdatetime": "02/21 19:49", "push_tag": "→", "push_userid": "redsaizu"}, {"push_content": "最有效的方法", "push_ipdatetime": "02/21 19:49", "push_tag": "→", "push_userid": "redsaizu"}, {"push_content": "基亞不就那個統創黃子亮搞得嗎", "push_ipdatetime": "02/21 19:49", "push_tag": "→", "push_userid": "BoyPlunger"}, {"push_content": "單純覺得這個新藥效果是好的但浩鼎過於自信。實驗設", "push_ipdatetime": "02/21 19:51", "push_tag": "→", "push_userid": "bluce2006"}, {"push_content": "計不良", "push_ipdatetime": "02/21 19:51", "push_tag": "→", "push_userid": "bluce2006"}, {"push_content": "樓上大哥...你不知道很多新藥都是死在設計不良嗎", "push_ipdatetime": "02/21 19:53", "push_tag": "推", "push_userid": "gingsow"}, {"push_content": "劑量太高導致副作用太強..選錯對照組..療程不對..", "push_ipdatetime": "02/21 19:54", "push_tag": "→", "push_userid": "gingsow"}, {"push_content": "藥效好不代表這個藥成功，好的臨床試驗設計也很重要", "push_ipdatetime": "02/21 19:55", "push_tag": "→", "push_userid": "gingsow"}, {"push_content": "可以請問公司為什麼要實驗設計不良，故意不給它成功", "push_ipdatetime": "02/21 19:57", "push_tag": "推", "push_userid": "DarkBuster"}, {"push_content": "台灣人才都在電機 醫學院", "push_ipdatetime": "02/21 19:58", "push_tag": "→", "push_userid": "clubbox"}, {"push_content": "是實驗設計不良，還是根本沒能力設計", "push_ipdatetime": "02/21 19:58", "push_tag": "→", "push_userid": "DarkBuster"}, {"push_content": "為何有信心改試驗設計就有信心過下次？之前不預防", "push_ipdatetime": "02/21 19:59", "push_tag": "推", "push_userid": "gismoxp"}, {"push_content": "一開始當然希望藥人人吃了都有效,有什麼好奇怪", "push_ipdatetime": "02/21 20:05", "push_tag": "推", "push_userid": "soulism"}, {"push_content": "台灣人才都在電機xd,基本上在我那時候醫科只要北醫", "push_ipdatetime": "02/21 20:22", "push_tag": "→", "push_userid": "meteorrain"}, {"push_content": "，扣掉生物都上的了台大電機的", "push_ipdatetime": "02/21 20:22", "push_tag": "→", "push_userid": "meteorrain"}, {"push_content": "設計不良都是事後說的，根本都是廢話", "push_ipdatetime": "02/21 20:23", "push_tag": "→", "push_userid": "abuu0929"}, {"push_content": "我事前就知道結果的話，根據結果來設計實驗不就好了", "push_ipdatetime": "02/21 20:23", "push_tag": "→", "push_userid": "abuu0929"}, {"push_content": "弄個藥當然是 誰都能吃>特定人能吃 如果特定族群小", "push_ipdatetime": "02/21 20:23", "push_tag": "→", "push_userid": "Justisaac"}, {"push_content": "就會不顯著　", "push_ipdatetime": "02/21 20:23", "push_tag": "→", "push_userid": "Justisaac"}, {"push_content": "不顯著不代表完全沒有效果", "push_ipdatetime": "02/21 20:24", "push_tag": "→", "push_userid": "Justisaac"}, {"push_content": "不過跌是一定的　因為重新準備一次要很多時間....", "push_ipdatetime": "02/21 20:25", "push_tag": "→", "push_userid": "Justisaac"}, {"push_content": "你不賣就等於準備跟浩鼎一起套牢到下次解盲", "push_ipdatetime": "02/21 20:27", "push_tag": "推", "push_userid": "dahlia7357"}, {"push_content": "再說期間有可能出一個新的療法 不就....", "push_ipdatetime": "02/21 20:28", "push_tag": "推", "push_userid": "g10"}, {"push_content": "他的講話絕大多數都馬後炮沒啥內容", "push_ipdatetime": "02/21 21:04", "push_tag": "噓", "push_userid": "Chris611"}, {"push_content": "之前不是都把尹捧得跟神一樣？炒作就是炒作", "push_ipdatetime": "02/21 21:09", "push_tag": "噓", "push_userid": "hegemon"}, {"push_content": "噓老洩", "push_ipdatetime": "02/21 21:16", "push_tag": "噓", "push_userid": "cuteolivia"}, {"push_content": "22根-10%就大約到基亞當時落底的價格了", "push_ipdatetime": "02/21 21:18", "push_tag": "→", "push_userid": "bonaqabo"}, {"push_content": "過個兩三年大家還是會繼續喊勿忘耗呆雞鴨", "push_ipdatetime": "02/21 21:21", "push_tag": "推", "push_userid": "kanyewest927"}, {"push_content": "幹 可惜不能空", "push_ipdatetime": "02/21 21:24", "push_tag": "噓", "push_userid": "wakauo"}, {"push_content": "失敗就是失敗+1", "push_ipdatetime": "02/21 21:27", "push_tag": "推", "push_userid": "s866217"}, {"push_content": "如果是看新聞做股票.還是賣一賣比較好睡覺.", "push_ipdatetime": "02/21 21:32", "push_tag": "推", "push_userid": "soulism"}, {"push_content": "台灣出這廢老頭真是悲哀", "push_ipdatetime": "02/21 21:48", "push_tag": "噓", "push_userid": "SkyShih"}, {"push_content": "潤泰集團也會跟著跌嗎？", "push_ipdatetime": "02/21 21:53", "push_tag": "推", "push_userid": "bezierman"}, {"push_content": "大家罵歸罵 記得雜誌要買啊", "push_ipdatetime": "02/21 22:14", "push_tag": "推", "push_userid": "Genki626"}, {"push_content": "謝金河是反指標，看來可以考慮進場了～", "push_ipdatetime": "02/21 22:46", "push_tag": "→", "push_userid": "purestone"}, {"push_content": "其實...這麼多股票有人當沖賺牛皮股上下差價也是賺", "push_ipdatetime": "02/21 23:17", "push_tag": "→", "push_userid": "eemail"}, {"push_content": "對於以賺錢為目的的高手執著於這支似乎有點莫名", "push_ipdatetime": "02/21 23:18", "push_tag": "→", "push_userid": "eemail"}, {"push_content": "工業4.0？ 呵呵", "push_ipdatetime": "02/21 23:50", "push_tag": "推", "push_userid": "db"}, {"push_content": "基因才是胖達人，某樓真是 ㄏㄏ", "push_ipdatetime": "02/22 06:26", "push_tag": "噓", "push_userid": "krishuang"}, {"push_content": "嘴砲大王", "push_ipdatetime": "02/22 09:38", "push_tag": "噓", "push_userid": "coolgigi"}, {"push_content": "你怎不早說呢？", "push_ipdatetime": "02/22 10:28", "push_tag": "推", "push_userid": "transcend789"}, {"push_content": "看到他說話就倒胃", "push_ipdatetime": "02/22 11:43", "push_tag": "噓", "push_userid": "KYmilk"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456054364.A.DD8.html"},
{"article_id": "M.1456055271.A.8CD", "article_title": "[請益] 請推薦沒有高深技術但又賺錢的低價股", "author": "RAVANA (雷瓦納)", "board": "Stock", "content": "看了一些關於巴菲特的書 都說盡量選項可口可樂這樣的股票 我覺得台灣未來的出路 不是高科技 而是低價的人力可以壓榨 所以我歸納出這種股要有幾種特性 1.產業不用高深技術 不用請很貴的攻城師分紅配股 可以請一些兩萬多的人來做就行了 2.不用跟中國韓國競爭 中國有在做的產業 一定是紅海微利 3.民生必需品 且業績穩定 金融海嘯來照樣要用的 4.公司夠大 不會亂搞 產業沒有劇烈景氣波動或政治波動 5.公司穩定配股配息 ================================================ 我知道這樣的公司大概幾家 1.震旦行 影印機、手機都要用 生活必需品 請一些兩萬多的年輕人就能做了 2.新保、中保 保全可以用低薪請中年失業的 大樓廠房只會越蓋越多 3.永大、崇友 大樓商場只會越蓋越多 電梯數量只會增加 會需要攻城師去保養 4.統一超 業務只會越來越多 功能只會越來越多 店只會越開越多 請一些工讀生就能做 5.和泰車 高低市場通吃 高階雷色司 低階Toyota台灣人都很愛開 還有沒有其他推薦的?? 有幾家可以 但他有些不符合 1.中鋼 大陸越南競爭現在已經變成慘業 2.建大、正新 做輪胎的 但不知道未來中國會不會競爭 3.大台北、新海 國際能源價格會劇烈波動 4.華票 配股投報很高 但不知道他是在做啥的 不知會不會有劇烈波動 我一直在找這類的股票 列為觀察鎖定 價錢到就買 但我的眼界只有發現這幾張 這些產業我眼界這麼小 都已經知道一些了 應該還有其他 負責攻城的 哈 就工程師啊 這加好像不錯 等等來研究 發電成本不是會隨國際能源價格波動嗎? 現在低點 會不會過幾年能源開始漲價 電價又不能隨便漲 成本開始墊高獲利就變差?? 有 口袋觀察名單 但股價一張兩百多 唉 沒錢 只能買零股 有推薦的股票嗎? 一切都不錯 但公司太小 怕他亂搞 股價波動太大 有點危險 讚 來研究他 這完全符合 有阿 投報率超高 股價超穩定 綠上台後 不知道觀光客會不會縮減 元大期不錯 但最近衝高 列入觀察 可能啊 因為公司可能之前已經卡好位了 把市場都吃光 並且打爛了 後面的人進來賺不到錢 微利 因為市場已經卡光了 他已經卡位好 以量衝營收 且摳死當的方法都成熟了 就大者恆大 穩定獲利 別人進不來 進來要燒錢 來觀察一下 不過公司有點小 這看起來不太穩定 去年還沒配股 可是配股太難看 來研究看看 我還以為是電子業的惠普 查不到這支 這個之前聽過 但配股不太高 而且成交張數太少 好像很難買賣 衝太高了 已經不好賺 鋼鐵這幾年已經變慘業了 跟電子業一樣 產能過剩 像保力達、維士比這種都沒有股票 上引水產三井集團也是 這看起來都好賺符合 有 我有新保和華票 最近想買永大和崇友但最近拉上來 股價是等出來的 所以我想跟大家多請教幾隻來鎖定 一併觀察 剛看他獲利好像不太穩定 某一季還虧損 花仙子不錯 剛突然想到一張 大車隊", "date": "Sun Feb 21 19:47:48 2016", "ip": "203.70.94.53", "message_count": {"all": 111, "boo": 5, "count": 50, "neutral": 51, "push": 55}, "messages": [{"push_content": "虫友 FJ概念股", "push_ipdatetime": "02/21 19:48", "push_tag": "推", "push_userid": "WANG122122"}, {"push_content": "台灣50 中華電(9X買不到)", "push_ipdatetime": "02/21 19:49", "push_tag": "推", "push_userid": "fomzantom"}, {"push_content": "你出來開一間", "push_ipdatetime": "02/21 19:49", "push_tag": "噓", "push_userid": "g10"}, {"push_content": "這樣大概要找內需且寡佔甚至獨佔的產業...", "push_ipdatetime": "02/21 19:50", "push_tag": "→", "push_userid": "Altair"}, {"push_content": "就華票吧", "push_ipdatetime": "02/21 19:50", "push_tag": "推", "push_userid": "cloud7515"}, {"push_content": "台灣50", "push_ipdatetime": "02/21 19:51", "push_tag": "推", "push_userid": "pigwannafly"}, {"push_content": "公用事業", "push_ipdatetime": "02/21 19:51", "push_tag": "→", "push_userid": "tsubasa"}, {"push_content": "要便宜的人力有更便宜的", "push_ipdatetime": "02/21 19:51", "push_tag": "噓", "push_userid": "mmkuo"}, {"push_content": "攻城師是3小？XD", "push_ipdatetime": "02/21 19:52", "push_tag": "推", "push_userid": "legendbrian"}, {"push_content": "聯華", "push_ipdatetime": "02/21 19:52", "push_tag": "推", "push_userid": "c902112"}, {"push_content": "台汽電", "push_ipdatetime": "02/21 19:52", "push_tag": "→", "push_userid": "c902112"}, {"push_content": "統一超", "push_ipdatetime": "02/21 19:53", "push_tag": "推", "push_userid": "yanki826"}, {"push_content": "FJ-ETF", "push_ipdatetime": "02/21 19:54", "push_tag": "→", "push_userid": "sinple"}, {"push_content": "我看的是玻陶、紡織", "push_ipdatetime": "02/21 19:54", "push_tag": "推", "push_userid": "giveUstars"}, {"push_content": "德麥，賣麵包夠簡單了吧", "push_ipdatetime": "02/21 19:55", "push_tag": "推", "push_userid": "shihchinlun"}, {"push_content": "台灣覆蓋率超高，非常符合你需求", "push_ipdatetime": "02/21 19:56", "push_tag": "→", "push_userid": "shihchinlun"}, {"push_content": "龍巖 每天都有死人", "push_ipdatetime": "02/21 19:56", "push_tag": "推", "push_userid": "TTLKING"}, {"push_content": "政府公債", "push_ipdatetime": "02/21 19:57", "push_tag": "推", "push_userid": "whitedeath"}, {"push_content": "銀行股阿XDDDD", "push_ipdatetime": "02/21 19:57", "push_tag": "推", "push_userid": "Lineage5415"}, {"push_content": "食品類", "push_ipdatetime": "02/21 20:01", "push_tag": "推", "push_userid": "david85dodo"}, {"push_content": "好樂迪也很符合，不用解釋好樂迪是幹嘛的吧", "push_ipdatetime": "02/21 20:04", "push_tag": "推", "push_userid": "shihchinlun"}, {"push_content": "華票有配股?", "push_ipdatetime": "02/21 20:06", "push_tag": "→", "push_userid": "opm"}, {"push_content": "fj etf", "push_ipdatetime": "02/21 20:14", "push_tag": "推", "push_userid": "henry3182001"}, {"push_content": "好樂迪真不錯！但現在有點高了，之前40以下沒買啊七", "push_ipdatetime": "02/21 20:16", "push_tag": "推", "push_userid": "jrfish"}, {"push_content": "點到我一堆股", "push_ipdatetime": "02/21 20:17", "push_tag": "推", "push_userid": "f204137"}, {"push_content": "有沒有補教業要上市的", "push_ipdatetime": "02/21 20:18", "push_tag": "推", "push_userid": "julian42"}, {"push_content": "山隆穩穩賺", "push_ipdatetime": "02/21 20:18", "push_tag": "→", "push_userid": "f204137"}, {"push_content": "fj最佳選擇。", "push_ipdatetime": "02/21 20:18", "push_tag": "推", "push_userid": "borry6299"}, {"push_content": "夏都，這幾年配不錯，但股價很少波動", "push_ipdatetime": "02/21 20:19", "push_tag": "→", "push_userid": "jrfish"}, {"push_content": "山隆現在感覺偏貴啊", "push_ipdatetime": "02/21 20:21", "push_tag": "→", "push_userid": "onok"}, {"push_content": "新保、中保不錯啦，但一樣是太貴", "push_ipdatetime": "02/21 20:22", "push_tag": "→", "push_userid": "onok"}, {"push_content": "你都看老巴了，不需要高深技術，薪水只拿兩萬請員工", "push_ipdatetime": "02/21 20:22", "push_tag": "推", "push_userid": "magickevin"}, {"push_content": "的公司怎麼會是她要的，你以為可口可樂跟吉列就會請", "push_ipdatetime": "02/21 20:22", "push_tag": "→", "push_userid": "magickevin"}, {"push_content": "茂矽", "push_ipdatetime": "02/21 20:22", "push_tag": "推", "push_userid": "aboveground"}, {"push_content": "買山隆感覺不如買台汽電", "push_ipdatetime": "02/21 20:22", "push_tag": "→", "push_userid": "onok"}, {"push_content": "物流業", "push_ipdatetime": "02/21 20:22", "push_tag": "推", "push_userid": "x246813"}, {"push_content": "很多低薪員工嗎，又為什麼會要選低價股", "push_ipdatetime": "02/21 20:23", "push_tag": "→", "push_userid": "magickevin"}, {"push_content": "其實元大期、群益期 是非常好的標的", "push_ipdatetime": "02/21 20:23", "push_tag": "→", "push_userid": "onok"}, {"push_content": "沒競爭,技術不難,沒景氣循環，公司大又要穩定賺錢配", "push_ipdatetime": "02/21 20:23", "push_tag": "推", "push_userid": "piglauhk"}, {"push_content": "股息嗎…", "push_ipdatetime": "02/21 20:23", "push_tag": "→", "push_userid": "piglauhk"}, {"push_content": "未來的浩鼎", "push_ipdatetime": "02/21 20:24", "push_tag": "→", "push_userid": "VISA01"}, {"push_content": "期貨商，大盤波動越大賺越多", "push_ipdatetime": "02/21 20:25", "push_tag": "→", "push_userid": "onok"}, {"push_content": "怎麼可能沒技術門檻賺錢又多，沒技術門檻那不就好複", "push_ipdatetime": "02/21 20:26", "push_tag": "推", "push_userid": "mwl655ms"}, {"push_content": "製，同業又競爭，毛利又變小", "push_ipdatetime": "02/21 20:26", "push_tag": "→", "push_userid": "mwl655ms"}, {"push_content": "不過群益期現在正準備要噴 低點已過", "push_ipdatetime": "02/21 20:27", "push_tag": "→", "push_userid": "onok"}, {"push_content": "中華電:有人找我?", "push_ipdatetime": "02/21 20:27", "push_tag": "→", "push_userid": "Justisaac"}, {"push_content": "未來群益期若有回到25元以下，你可以買來放長線", "push_ipdatetime": "02/21 20:28", "push_tag": "→", "push_userid": "onok"}, {"push_content": "0050  0050  0050  0050  0050  0050  選我正解", "push_ipdatetime": "02/21 20:28", "push_tag": "→", "push_userid": "victoryss"}, {"push_content": "就你自己的公司啊", "push_ipdatetime": "02/21 20:28", "push_tag": "噓", "push_userid": "asiu"}, {"push_content": "3551", "push_ipdatetime": "02/21 20:29", "push_tag": "推", "push_userid": "ooxx123"}, {"push_content": "山龍我又沒叫你買~ 我買在17.X", "push_ipdatetime": "02/21 20:30", "push_tag": "推", "push_userid": "f204137"}, {"push_content": "群益期˙ 我先前也喊滿兇der", "push_ipdatetime": "02/21 20:31", "push_tag": "→", "push_userid": "f204137"}, {"push_content": "你不是最會請22K以下免洗的來壓榨嗎", "push_ipdatetime": "02/21 20:33", "push_tag": "噓", "push_userid": "asiu"}, {"push_content": "把你公司買下來最賺", "push_ipdatetime": "02/21 20:33", "push_tag": "→", "push_userid": "asiu"}, {"push_content": "虫友棒棒", "push_ipdatetime": "02/21 20:34", "push_tag": "→", "push_userid": "WANG122122"}, {"push_content": "保全公司符合你所需。", "push_ipdatetime": "02/21 20:35", "push_tag": "→", "push_userid": "morelife"}, {"push_content": "他說低價股", "push_ipdatetime": "02/21 20:36", "push_tag": "→", "push_userid": "DareJ"}, {"push_content": "現在二代健保稅抽那麼重扣抵還折半  為何要選派股", "push_ipdatetime": "02/21 20:36", "push_tag": "推", "push_userid": "piglauhk"}, {"push_content": "息的", "push_ipdatetime": "02/21 20:36", "push_tag": "→", "push_userid": "piglauhk"}, {"push_content": "5530完全符合你要求。", "push_ipdatetime": "02/21 20:37", "push_tag": "→", "push_userid": "piglauhk"}, {"push_content": "中華電啊", "push_ipdatetime": "02/21 20:40", "push_tag": "推", "push_userid": "monarch0301"}, {"push_content": "0056或0050", "push_ipdatetime": "02/21 20:47", "push_tag": "→", "push_userid": "humbler"}, {"push_content": "1605 ，", "push_ipdatetime": "02/21 20:52", "push_tag": "推", "push_userid": "soaringwings"}, {"push_content": "賺錢怎麼會低價?  低價不會是賺錢der", "push_ipdatetime": "02/21 20:56", "push_tag": "→", "push_userid": "TouSan"}, {"push_content": "誰說低價不會賺錢的？", "push_ipdatetime": "02/21 20:58", "push_tag": "→", "push_userid": "onok"}, {"push_content": "說股價低就不會賺錢感覺需要進修一點知識~", "push_ipdatetime": "02/21 20:59", "push_tag": "→", "push_userid": "Justisaac"}, {"push_content": "股本大小差很多好不好XD", "push_ipdatetime": "02/21 21:00", "push_tag": "→", "push_userid": "Justisaac"}, {"push_content": "日友，處理醫療廢棄物，高年紀社會老人多", "push_ipdatetime": "02/21 21:01", "push_tag": "推", "push_userid": "ninet"}, {"push_content": "補教業有呀  6294", "push_ipdatetime": "02/21 21:11", "push_tag": "推", "push_userid": "irawang"}, {"push_content": "8424  啦    一定符合你要求", "push_ipdatetime": "02/21 21:11", "push_tag": "→", "push_userid": "irawang"}, {"push_content": "我佛心來也，告訴你名牌：8359！別太感謝我", "push_ipdatetime": "02/21 21:13", "push_tag": "推", "push_userid": "skindeep"}, {"push_content": "中華豆腐...", "push_ipdatetime": "02/21 21:17", "push_tag": "推", "push_userid": "redsaizu"}, {"push_content": "2412", "push_ipdatetime": "02/21 21:19", "push_tag": "推", "push_userid": "wu322016"}, {"push_content": "2892", "push_ipdatetime": "02/21 21:20", "push_tag": "→", "push_userid": "starport"}, {"push_content": "做廢棄物處理得應該算", "push_ipdatetime": "02/21 21:22", "push_tag": "推", "push_userid": "exrickey"}, {"push_content": "南仁湖", "push_ipdatetime": "02/21 21:43", "push_tag": "推", "push_userid": "coburn"}, {"push_content": "中鋼放20-30年你會不放心嗎？", "push_ipdatetime": "02/21 21:50", "push_tag": "推", "push_userid": "deii"}, {"push_content": "如果只是要穩定賺股息 比中鋼好的標的 其實非常多", "push_ipdatetime": "02/21 21:56", "push_tag": "→", "push_userid": "onok"}, {"push_content": "1220", "push_ipdatetime": "02/21 21:57", "push_tag": "推", "push_userid": "myandydesk"}, {"push_content": "8424", "push_ipdatetime": "02/21 22:01", "push_tag": "→", "push_userid": "AdaJohn"}, {"push_content": "華票！一次丟50萬。", "push_ipdatetime": "02/21 22:02", "push_tag": "推", "push_userid": "les0818"}, {"push_content": "台灣高鐵", "push_ipdatetime": "02/21 22:04", "push_tag": "推", "push_userid": "diamondX"}, {"push_content": "討論這麼多，先進市場再來討論吧，否則老實說沒感覺", "push_ipdatetime": "02/21 22:17", "push_tag": "推", "push_userid": "howard172"}, {"push_content": "華票做RP，附買回，所以很穩。", "push_ipdatetime": "02/21 22:46", "push_tag": "推", "push_userid": "clark0816"}, {"push_content": "9905大華 1904正隆", "push_ipdatetime": "02/21 22:57", "push_tag": "推", "push_userid": "a1230030721"}, {"push_content": "票券業很穩，只是也沒甚麼成長性就是了，降息受惠股", "push_ipdatetime": "02/21 23:14", "push_tag": "推", "push_userid": "leon99"}, {"push_content": "票券業通常都會歸在金控底下，以後應該會併入台工銀", "push_ipdatetime": "02/21 23:15", "push_tag": "→", "push_userid": "leon99"}, {"push_content": "不然我覺得宏亞也不錯，77乳加巧克力概念股XDD", "push_ipdatetime": "02/21 23:17", "push_tag": "→", "push_userid": "leon99"}, {"push_content": "花仙子能否考慮一下？", "push_ipdatetime": "02/21 23:39", "push_tag": "推", "push_userid": "aniki9mmd"}, {"push_content": "花仙子高了", "push_ipdatetime": "02/22 00:02", "push_tag": "→", "push_userid": "DareJ"}, {"push_content": "做點功課吧", "push_ipdatetime": "02/22 00:47", "push_tag": "→", "push_userid": "leon99"}, {"push_content": "金融股", "push_ipdatetime": "02/22 00:48", "push_tag": "→", "push_userid": "dapaochiu"}, {"push_content": "義美", "push_ipdatetime": "02/22 00:48", "push_tag": "推", "push_userid": "infit"}, {"push_content": "我認真推-豐藝、遠東新、亞泥、鴻海", "push_ipdatetime": "02/22 00:49", "push_tag": "推", "push_userid": "bigair888"}, {"push_content": "跪求宗教慨念股！", "push_ipdatetime": "02/22 01:06", "push_tag": "→", "push_userid": "agog2008"}, {"push_content": "可以考慮福興哦，穩穩賺～老闆娘是我爸同學，保證三", "push_ipdatetime": "02/22 04:50", "push_tag": "→", "push_userid": "zozasa"}, {"push_content": "個月股價會慢慢上去（大盤穩定前提下）", "push_ipdatetime": "02/22 04:50", "push_tag": "→", "push_userid": "zozasa"}, {"push_content": "研勤", "push_ipdatetime": "02/22 05:34", "push_tag": "推", "push_userid": "rugall"}, {"push_content": "第一金", "push_ipdatetime": "02/22 07:06", "push_tag": "→", "push_userid": "wu322016"}, {"push_content": "寶成 台鹽 遠百 藍天 長興 中石化", "push_ipdatetime": "02/22 09:25", "push_tag": "推", "push_userid": "pig0038"}, {"push_content": "永豐餘 台船 長榮航", "push_ipdatetime": "02/22 09:27", "push_tag": "→", "push_userid": "pig0038"}, {"push_content": "2888新光金", "push_ipdatetime": "02/22 11:39", "push_tag": "推", "push_userid": "city3026"}, {"push_content": "台灣除了中華電信沒別的了", "push_ipdatetime": "02/22 12:37", "push_tag": "推", "push_userid": "stosto"}, {"push_content": "大統液", "push_ipdatetime": "02/22 14:35", "push_tag": "推", "push_userid": "korn2237386"}, {"push_content": "健身工廠那張? 柏文?", "push_ipdatetime": "02/22 17:03", "push_tag": "推", "push_userid": "DAVIDWAY"}, {"push_content": "謝謝分享", "push_ipdatetime": "02/22 18:46", "push_tag": "噓", "push_userid": "marksky"}, {"push_content": "可以買炒股", "push_ipdatetime": "02/22 19:08", "push_tag": "→", "push_userid": "dapaochiu"}, {"push_content": "你就找低本益比產業又剛好符合你想要的就好了...", "push_ipdatetime": "02/23 00:46", "push_tag": "推", "push_userid": "sky004"}, {"push_content": "還有你平常看到的東西賣的好但不一定公司就是賺錢", "push_ipdatetime": "02/23 00:50", "push_tag": "推", "push_userid": "sky004"}, {"push_content": "產品賣不好不一定公司就是不賺錢，前提你要真了解", "push_ipdatetime": "02/23 00:51", "push_tag": "→", "push_userid": "sky004"}, {"push_content": "公司營運不是看看表面讀讀財報", "push_ipdatetime": "02/23 00:51", "push_tag": "→", "push_userid": "sky004"}], "url": "https://www.ptt.cc/bbs/Stock/M.1456055271.A.8CD.html"}]}